Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
1616796	cb-vekaas	— (—)	10290	38175	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Diabetes, insulin treatment (Kela reimbursement)

2486

6147

2.46

323.31

4.5

3.3

—

Other chronic obstructive pulmonary disease

1410

3770

3.20

318.05

5.5

3.5

—

Endocrine, nutritional and metabolic diseases

1655

2722

3.13

317.07

4.1

2.8

—

Hypo-osmolality and hyponatraemia

718

1537

4.96

311.22

4.8

3.6

—

2828

4144

4.14

307.65

5.1

2.8

—

Pneumonias (Asthma/COPD co-morbidities)

3225

5818

3.75

307.65

5.1

2.8

—

ILD medications: prednisolone, methylprednisolone, prednisone

2793

6091

2.61

307.65

5.2

2.9

—

All kidney diseases

3405

5672

4.19

307.65

5.4

2.6

—

Glomerular disorders in diseases classified elsewhere

683

1045

7.39

307.65

8.7

3.6

—

Implicit viral Sepsis

901

1767

5.47

307.65

6.9

2.8

—

Explicit Sepsis

1802

3670

4.74

307.65

6.0

2.7

—

Insulin, fast-acting

1284

3632

3.72

307.65

5.7

3.5

—

ILD, hospital admission 2, with pulmonary infections

474

666

7.84

307.65

5.8

3.0

—

Insulin medication

1955

4992

3.38

307.65

5.2

3.5

—

Heart failure,strict

1985

3046

4.82

307.65

5.9

2.8

—

Heart failure and antihypertensive medication

977

821

8.27

307.65

6.6

2.5

—

Malaise and fatigue

1764

3480

4.16

307.65

3.8

3.5

—

Type 2 diabetes, wide definition

2171

4631

3.05

307.65

4.9

3.3

—

Renal failure

2759

3988

6.47

307.65

6.6

2.9

—

Persons encountering health services in other circumstances

1756

3670

5.03

307.65

4.1

3.1

—

Influenza and pneumonia

3207

5718

3.58

307.65

5.0

2.8

—

COPD/asthma related infections

2299

4144

2.84

307.65

4.4

2.8

—

Diabetes mellitus

2503

5618

2.63

307.65

4.3

3.2

—

Dyspnoea

2672

6737

2.95

307.65

4.5

3.5

—

Viral Sepsis

901

1769

5.47

307.65

6.9

2.8

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

452

319

10.69

307.65

5.8

3.1

—

Pneumonia, organism unspecified

3129

5462

4.09

307.65

5.1

2.8

—

COPD (mode)

1109

1523

6.01

307.65

5.5

2.8

—

Hypertensive diseases

1826

3266

3.24

307.65

4.8

2.7

—

Acute tubulo-interstitial nephritis

1786

4602

3.39

307.65

5.2

2.7

—

Care involving dialysis

646

593

13.21

307.65

11.9

3.3

—

Other heart diseases

1097

1583

4.64

307.65

5.5

2.2

—

Covid-19 confirmed case

1434

4042

3.74

307.65

5.2

3.5

—

Metabolic disorders

2429

5542

2.70

307.65

4.5

3.3

—

Sleep apnoea, including avohilmo

2619

6101

2.66

307.65

3.8

3.6

—

Acute renal failure

1191

1951

6.73

307.65

6.8

2.9

—

General symptoms and signs

2542

4565

2.85

307.65

4.0

3.4

—

Oral corticosteroids

2738

6560

2.50

307.65

4.6

3.2

—

Insulin, fast-acting or short human

1291

3848

3.52

307.65

5.6

3.5

—

Other bacterial diseases, including avohilmo

2891

6019

3.09

307.65

5.0

3.1

—

Renal tubulo-interstitial diseases

3414

5609

4.69

307.65

5.8

2.6

—

Explicit Sepsis, including avohilmo

1825

3729

4.70

307.65

6.0

2.7

—

Persons encountering health services for specific procedures and health care

2846

6116

2.82

307.65

5.3

2.8

—

COPD

1481

3900

3.22

307.65

5.4

3.5

—

Other respiratory disorders and diseases

979

2128

4.99

307.65

8.2

3.3

—

Heart failure and coronary heart disease

1526

3127

3.60

307.65

5.8

3.5

—

Heart failure and bmi 25plus

1306

2396

3.85

307.65

6.0

3.3

—

Nephropathy related operations

846

1105

8.94

307.65

11.1

3.6

—

Implicit viral Sepsis, including avohilmo

1132

2651

4.50

307.65

6.4

2.7

—

Insulin, intermediate and long-acting

1773

5782

3.08

307.65

5.1

3.5

—

ILD medications

2779

6164

2.48

307.65

5.1

2.9

—

Insulin, combination of fast acting with intermediate-acting or long-acting

1957

6156

2.99

307.65

5.2

3.5

—

Heart failure, not strict

2632

4123

4.51

307.65

6.0

2.7

—

Transplanted organ and tissue status

575

703

9.29

307.65

10.5

3.6

—

Kidney transplant status

421

378

13.66

307.65

11.9

3.5

—

Codes for special purposes

1619

5741

2.90

307.65

5.1

3.4

—

Sleep apnoea

2596

6028

2.79

307.65

3.8

3.6

—

Implicit bacterial Sepsis, including avohilmo

1832

3571

4.51

307.65

6.2

2.7

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

2762

5252

3.68

307.65

5.4

2.6

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

655

725

6.51

307.65

6.1

2.3

—

All-cause Heart Failure

2109

3925

3.94

307.65

5.7

3.2

—

Glomerular diseases

957

1668

6.35

307.65

8.5

3.6

—

Bacterial infection, other or unspecified

1761

4415

3.51

307.65

5.1

3.2

—

Type 2 diabetes

2338

5370

2.58

307.65

4.3

3.2

—

Other medical care

1789

3939

4.00

307.65

4.7

3.0

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

2975

6616

3.13

307.65

5.0

3.2

—

ILD medications: immunosuppressive drugs

1666

5381

2.88

307.65

6.2

2.9

—

Dialysis

332

256

16.15

307.65

12.3

3.2

—

Condition for Implicit Sepsis (Organ dysfunction codes)

2769

5234

3.81

307.65

5.6

2.6

—

Bacterial Sepsis

1906

3651

4.57

307.65

6.2

2.7

—

Implicit Sepsis, including avohilmo

2812

5222

4.01

307.65

5.7

2.6

—

Asthma, unspecified (mode)

1355

2490

4.05

307.65

4.3

2.6

—

Extracorporeal dialysis

482

538

10.93

307.65

12.0

3.9

—

Hypertensive diseases (excluding secondary)

1241

1534

4.85

307.65

5.0

2.1

—

Bacterial infection, other or unspecified, including avohilmo

1894

4626

3.49

307.65

5.1

3.2

—

Implicit Sepsis

2760

5001

4.26

307.65

5.8

2.6

—

Other disorders of fluid, electrolyte and acid-base balance

1445

2819

5.18

307.65

5.3

3.5

—

Chronic kidney disease

2080

2983

7.52

307.65

7.4

2.9

—

Cardiovascular diseases (excluding rheumatic etc)

1306

2081

3.67

307.65

4.7

2.1

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

2331

5294

2.68

307.65

4.5

3.2

—

First line medication for Crohn's disease

2756

5759

2.63

307.65

4.8

2.9

—

Provisional assignment of new diseases of uncertain etiology

1618

5737

2.90

307.65

5.1

3.4

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

2429

6197

2.53

307.65

5.1

3.2

—

Asthma

1643

2617

3.31

307.65

4.0

2.6

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

3141

5969

3.63

307.65

5.1

2.9

—

L04AD Calcineurin inhibitors

595

843

7.93

307.65

10.3

3.7

—

Fever of other and unknown origin

1960

4057

4.37

307.65

5.0

3.4

—

GASTRO-related operations

1661

2673

3.18

307.65

4.3

2.5

—

Asthma (only as main-diagnosis), excluding more controls

1407

2214

3.59

307.65

3.8

2.5

—

Asthma, unspecified (mode), excluding more controls

1301

2097

4.58

307.65

4.2

2.5

—

Other bacterial diseases

2971

6001

3.40

307.65

5.0

3.1

—

All pneumoniae

3225

5844

3.72

307.65

5.1

2.8

—

Presence of other functional implants

1941

4110

3.37

307.65

4.2

3.6

—

Anaemias

738

317

15.69

307.65

5.7

2.0

—

COPD/asthma/ILD related infections

2299

4144

2.84

307.65

4.4

2.8

—

Other diseases of the respiratory system

979

2128

4.99

307.65

8.2

3.3

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

2828

4144

4.14

307.65

5.1

2.8

—

Septicaemia

1756

3819

4.45

307.65

6.1

3.3

—

Asthma, excluding more controls

1560

2214

3.70

307.65

4.0

2.5

—

Dialysis, with operation codes

851

933

10.59

307.65

10.8

3.1

—

Other septicaemia

1599

3519

4.55

307.65

6.1

3.3

—

Early onset COPD, excluding more controls

649

1144

5.98

307.65

5.7

2.9

—

Other diseases of pleura

1866

4194

4.11

307.65

6.3

3.3

—

Aplastic and other anaemias

1558

4808

3.09

307.65

5.6

3.5

—

All chronic kidney diseases

2721

3752

6.23

307.65

6.4

2.7

—

Respiratory insufficiency

579

442

15.15

307.65

9.7

2.7

—

Heart failure, strict

2143

3987

3.93

307.65

5.7

3.2

—

Secondary hypertension

522

317

18.65

307.65

9.4

2.1

—

Hypertension

1825

3264

3.23

307.65

4.8

2.7

—

Implicit bacterial Sepsis

1721

3348

4.68

307.65

6.4

2.7

—

Other septicaemia, including avohilmo

1620

3579

4.51

307.65

6.1

3.3

—

Hypertension, essential

1776

3173

3.25

307.65

4.5

2.7

—

Abnormalities of breathing

2394

4564

3.08

307.65

4.1

3.4

—

Diabetes, varying definitions

2479

5636

2.61

307.65

4.3

3.2

—

Any gastric operation

1661

2673

3.18

307.65

4.3

2.5

—

Any reimbursement code in KELA

1058

1272

4.25

306.12

4.1

1.8

—

Inflammatory bowel disease treatment related agents

2741

6711

2.31

305.46

4.7

3.2

—

Any death

1748

4505

2.81

304.19

5.2

3.4

—

ILD, hospital admissions 3, with pneumonia sepsis

440

613

7.99

304.18

6.0

3.1

—

Oxycodone

1216

3223

3.35

301.67

4.5

3.6

—

Asthma (only as main-diagnosis)

1462

2617

3.19

298.87

3.8

2.6

—

Persons encountering health services in other circumstances, wide

2700

6120

2.31

294.84

4.7

3.2

—

Non-ischemic cardiomyopathy

981

2102

3.88

293.72

5.4

3.1

—

Viral pneumonia

524

913

6.16

289.78

6.2

2.9

—

Later onset COPD, excluding more controls

690

1078

5.15

288.32

5.4

2.7

—

Diabetes medication

2433

6157

2.36

286.97

4.3

3.3

—

COPD, hospital admissions

1429

4235

2.96

285.47

5.5

3.6

—

Other and unspecified anaemias

1387

4571

2.96

285.16

5.2

3.5

—

Other chronic obstructive pulmonary disease, including avohilmo

1604

4910

2.78

285.06

5.2

3.6

—

Other anaemias

1394

4594

2.95

284.84

5.2

3.5

—

Other pulmonary diagnosis

1565

2641

3.03

283.48

4.2

2.6

—

L04AA Selective immunosuppressants

783

1953

4.25

281.74

8.5

3.4

—

COPD, early/later onset

1429

4267

2.93

279.37

5.5

3.6

—

Erysipelas, including avohilmo

1790

5207

2.61

277.91

4.9

3.1

—

Other heart diseases, wide

1989

4840

2.54

277.63

4.8

3.0

—

Excluding asthma or asthma-COPD overlap

1550

2641

3.00

276.35

4.2

2.6

—

COPD, hospital admission 2, with asthma infections

1133

3086

3.32

274.14

6.0

3.5

—

Invasive ventilation

415

611

7.68

274.07

7.8

3.6

—

ILD differential diagnosis

1544

2639

2.99

273.87

4.2

2.6

—

COPD differential diagnosis

1544

2640

2.99

273.74

4.2

2.6

—

Depression medications

536

350

7.88

270.85

3.1

2.0

—

Infections, IBD-co-morbidities

450

422

7.83

270.03

6.9

3.1

—

COPD related to multimorbidity

1293

3767

3.03

268.54

5.5

3.5

—

Asthma (mode)

1472

2639

2.99

265.35

3.7

2.6

—

Disorders resulting from impaired renal tubular function

296

307

11.90

264.13

10.8

3.8

—

Unspecified kidney failure

477

836

6.22

263.31

6.8

3.1

—

Hypothyroidism (congenital or acquired)

469

330

8.15

258.47

3.7

2.0

—

Bronchitis

2582

7242

2.18

256.41

4.6

3.3

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

989

2575

3.47

255.42

6.2

3.5

—

Disorders of other endocrine glands

1240

4301

2.93

255.06

5.5

3.4

—

Atrial fibrillation and flutter

680

927

4.88

254.85

4.9

2.2

—

Volume depletion

469

837

6.12

254.16

6.4

3.7

—

Hypothyroidism and >3 levothyroxin purchases

462

329

8.06

252.83

3.5

2.0

—

Hypothyroidism, levothyroxine purchases

462

329

8.06

252.83

3.5

2.0

—

Substance abuse, excluding more controls

1456

4598

2.72

251.70

4.0

3.7

—

Intracranial trauma

1292

3003

2.97

249.83

3.9

3.6

—

Erysipelas

1439

4706

2.71

248.84

5.1

3.2

—

Hyperlipidaemia, other/unspecified

1143

3496

3.05

245.73

4.4

3.5

—

Cardiac arrhythmias

1142

2349

3.18

243.84

4.2

2.7

—

Cardiovascular diseases

1141

1862

3.32

243.47

4.5

2.1

—

Other acute lower respiratory infections

1494

5643

2.59

241.59

5.3

3.5

—

Tramadol

1777

4357

2.50

240.85

4.4

3.4

—

Type 1 diabetes

734

1953

3.91

239.37

5.8

3.4

—

Pulmonary heart disease, diseases of pulmonary circulation

1027

3395

3.16

239.06

5.1

3.6

—

Type 2 diabetes, definitions combined

2052

5219

2.33

236.98

3.9

3.2

—

Type 1 diabetes, wide definition, subgroup 1

625

1500

4.36

235.40

5.8

3.5

—

Valvular heart disease excluding rheumatic fever

1146

2754

3.06

235.15

5.1

3.1

—

Benzodiazepine use

2384

7646

2.14

234.29

4.1

3.5

—

Type 2 diabetes, strict (exclude DM1)

2057

5286

2.31

232.10

3.9

3.2

—

Non-rheumatic valve diseases

1137

2739

3.05

232.00

5.1

3.1

—

Acute bronchitis

1208

4332

2.83

231.87

5.5

3.5

—

Other nutritional deficiencies

1632

6248

2.44

231.65

4.9

3.5

—

Concussion

1127

2977

3.00

230.75

3.6

—

Atrial fibrillation and flutter with reimbursement

566

691

5.34

230.46

4.5

2.3

—

Antihypertensive medication - note that there are other indications

1154

1933

3.18

229.78

4.7

2.2

—

Diabetic nephropathy, excluding more controls

678

1388

4.32

229.35

7.5

3.3

—

Nausea and vomiting

831

2408

3.50

228.53

4.8

3.7

—

Codeine

1991

4673

2.34

228.28

3.7

3.3

—

Bleeding

2038

6486

2.25

227.05

4.7

3.6

—

Diarrhoea and gastroenteritis of presumed infectious origin

1767

6894

2.34

226.94

5.0

3.3

—

Other CVD (FINNGEN)

365

376

7.83

226.83

4.3

2.2

—

Pleural effusion

599

1443

4.44

226.71

5.2

3.2

—

Type 2 diabetes, definitions combined, including avohilmo

2029

5219

2.29

224.70

3.8

3.2

—

Other dialysis

247

256

11.99

220.82

13.2

4.2

—

Convulsions, not elsewhere classified

659

1696

3.98

220.81

4.3

3.5

—

Type 1 diabetes, wide definition

640

1644

4.06

219.64

5.8

3.5

—

Exposure to unspecified factor

2373

7856

2.09

219.44

4.3

3.5

—

Morphin

209

170

15.40

219.35

6.8

4.0

—

Obesity related asthma

987

3346

3.06

219.23

4.5

3.6

—

Cerebrovascular diseases (FINNGEN)

632

1034

4.40

217.89

4.5

2.2

—

Ischemic heart diseases

1834

4736

2.36

217.43

4.9

3.3

—

Extreme obesity with alveolar hypoventilation

261

297

10.27

215.43

8.5

3.1

—

Chronic lower respiratory diseases

2649

6957

2.04

215.04

4.4

3.4

—

Obesity due to excess calories

1197

4550

2.71

213.45

5.0

3.4

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1438

4572

2.54

212.96

4.8

3.7

—

Mental and behavioural disorders due to psychoactive substance use

1535

5968

2.42

212.36

4.0

3.8

—

Diabetic maculopathy, excluding more controls

424

811

5.62

212.35

6.3

3.7

—

2483

6133

2.09

212.06

4.4

3.3

—

Hypokalaemia

464

966

5.13

210.63

4.2

3.5

—

Other antidepressants

2290

5551

2.14

209.47

3.9

3.7

—

Asthma, hospital admission 2, infections

1537

6443

2.38

209.01

4.5

3.6

—

Asthma-related infections

1537

6443

2.38

209.01

4.5

3.6

—

Pain in throat and chest

1751

4488

2.35

207.43

3.6

3.4

—

Sleep disorders (combined)

2390

6071

2.09

206.99

3.7

—

Asthma-related pneumonia

1093

4026

2.80

206.63

5.1

3.6

—

Asthma-related pneumonia or sepsis

1094

4035

2.80

206.27

5.1

3.6

—

Asthma, hospital admissions 3, pneumonia

1094

4035

2.80

206.27

5.1

3.6

—

Syncope and collapse

1086

3266

2.85

205.60

3.7

3.5

—

Gout

936

2691

3.12

205.38

6.1

3.6

—

Symptoms and signs involving the circulatory and respiratory systems

2011

4569

2.24

204.19

3.8

3.4

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

785

1388

3.64

204.11

4.4

2.1

—

Opioids

2012

4742

2.23

203.05

3.9

3.3

—

Other respiratory diseases principally affecting the interstitium

672

1902

3.75

202.56

5.7

3.8

—

Iron deficiency anaemia

1202

4606

2.64

202.39

5.0

3.5

—

Intestinal infectious diseases

2185

7965

2.08

202.17

4.9

3.4

—

All influenza

709

2068

3.56

201.85

5.7

3.0

—

Percutaneous Coronary Intervention

1726

4601

2.33

201.11

4.9

3.3

—

Adjustment and management of implanted device

621

1676

3.91

200.13

4.4

3.2

—

Pulmonary embolism

903

3079

3.06

199.04

4.7

3.6

—

Hypertensive heart and/or renal disease

710

1438

3.74

199.03

5.7

3.0

—

Complications of surgical and medical care, not elsewhere classified

2277

7544

2.05

198.76

4.6

3.5

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

668

1863

3.65

198.60

3.5

—

Other disorders of kidney and ureter

523

1262

4.46

198.12

8.8

3.9

—

Nutritional anaemias

1347

5331

2.48

197.90

4.8

3.6

—

Hyperkalaemia

315

488

7.19

197.85

7.7

3.6

—

Obesity

1490

6074

2.36

197.77

5.1

3.4

—

Obesity and other hyperalimentation

1495

6094

2.36

197.73

5.0

3.4

—

Parasetamol

1449

2902

2.57

196.99

4.0

3.3

—

1539

5859

2.34

196.42

4.0

3.8

—

Hernia of abdominal wall, postoperative

486

1096

4.58

196.05

5.3

2.8

—

Certain infectious and parasitic diseases

1927

4379

2.24

195.39

4.5

2.8

—

Hard cardiovascular diseases

1784

4730

2.27

195.28

4.7

3.4

—

Coronary revascularization (ANGIO or CABG)

1712

4603

2.31

194.99

4.9

3.3

—

Episodal and paroxysmal disorders

2265

5583

2.09

194.75

3.7

3.6

—

Other (not insulin) diabetes medications

2081

5844

2.13

194.00

3.9

3.3

—

Pulmonary heart disease

903

3125

3.01

193.82

4.7

3.7

—

Glomerulonephritis

417

861

5.26

192.22

8.4

4.0

—

1480

5768

2.35

191.30

4.0

3.9

—

Other interstitial pulmonary diseases

590

1596

3.95

190.54

5.4

3.9

—

Substance abuse

1456

5904

2.35

189.55

4.0

3.8

—

Interstitial lung disease endpoints

590

1613

3.91

187.64

5.4

3.9

—

Interstitial lung disease

590

1613

3.91

187.64

5.4

3.9

—

Venous thromboembolism

1387

5793

2.37

184.92

4.6

3.6

—

ILD, hospital admissions

580

1591

3.89

183.60

5.4

3.9

—

Personality disorders, excluding more controls

598

1660

3.71

182.41

3.8

3.5

—

Gout, FINNGEN

936

3391

2.86

182.31

6.1

3.6

—

COPD-related respiratory insufficiency

473

1132

4.49

181.14

8.8

3.7

—

Mental and behavioural disorders due to alcohol

1308

5314

2.41

180.65

3.9

—

COPD, hospital admissions 1, only main diagnosis

1038

3396

2.73

179.74

5.8

3.7

—

Oedema, not elsewhere classified

810

2682

3.04

178.32

4.8

3.5

—

Anaemia in chronic diseases classified elsewhere

190

184

12.65

177.71

10.7

3.5

—

Gout, strict definition

659

2013

3.47

176.50

6.3

3.7

—

Polyarthropathies

1598

4648

2.25

175.20

5.2

3.4

—

Poisoning by drugs, medicaments and biological substances

646

1957

3.43

173.58

3.8

3.6

—

Poisoning by medicine

603

1751

3.58

173.34

3.7

—

Alcohol use disorder, Swedish definition

1383

5569

2.31

173.30

4.1

3.9

—

Major coronary heart disease event

1801

5120

2.14

172.14

5.0

3.4

—

Diseases of arteries, arterioles and capillaries

1637

5612

2.19

171.96

5.1

3.6

—

Hydronephrosis

382

800

5.06

171.89

5.5

2.9

—

DVT of lower extremities and pulmonary embolism

1128

4612

2.51

171.66

4.7

3.7

—

Emergency coronary revascularization (for ACS)

1872

5466

2.11

171.48

4.9

3.5

—

Gout, unspecified

705

2285

3.25

170.88

6.3

3.8

—

Gout, idiopatic and unspecified

820

2894

2.97

170.61

6.2

3.8

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

488

1255

4.07

168.02

3.7

3.5

—

Neurological diseases, wide definition

542

617

4.50

167.84

3.4

2.8

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1605

6638

2.15

167.27

4.8

3.6

—

Viral pneumonia (unknown virus, not influenza)

308

552

6.10

166.48

6.8

3.7

—

Autoimmune diseases excluding thyroid diseases

2192

6100

1.98

165.54

4.5

3.3

—

Diseases of the respiratory system

1153

2225

2.64

165.22

4.2

2.6

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

713

2290

3.15

164.31

3.3

3.9

—

Symptoms and signs involving the urinary system

1762

6513

2.08

164.23

4.2

3.7

—

Other and unspecified iron deficiency

940

3609

2.69

164.22

4.8

3.5

—

Neurological diseases

1657

3816

2.21

163.99

3.7

3.6

—

Codeine or tramadol medication

2372

6829

1.91

163.48

3.8

3.6

—

Lung cancer and mesothelioma

484

1031

4.13

163.30

4.1

2.8

—

403

922

4.57

161.98

4.7

3.0

—

1091

4492

2.47

161.45

4.6

3.5

—

Early onset COPD

649

2070

3.28

160.98

5.7

3.6

—

Contact with and exposure to communicable diseases

718

2406

3.06

160.76

3.6

3.4

—

Persons with potential health hazards related to communicable diseases

859

3182

2.75

157.95

3.9

3.6

—

Other disorders of urethra and urinary system

1570

5170

2.15

157.32

4.6

3.5

—

Pacemaker

1050

4023

2.51

156.77

4.6

3.8

—

Autoimmune diseases excluding thyroid diseases, strict definition

2103

5904

1.97

156.65

4.5

3.3

—

Constipation

1987

6950

1.97

156.30

4.2

3.7

—

Paroxysmal tachycardia

442

884

4.27

155.87

5.1

2.2

—

Biguanides

1987

6148

1.98

155.19

3.8

3.5

—

Coronary atherosclerosis

1387

3931

2.27

154.41

5.0

3.4

—

Conduction disorders

717

1918

3.09

154.41

4.5

3.1

—

Autoimmune diseases

2277

6131

1.91

153.71

4.3

3.3

—

Other diseases of blood and blood-forming organs, wide

649

2128

3.19

153.59

4.8

3.8

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1132

4846

2.38

153.48

4.0

3.9

—

Disorders of gallbladder, biliary tract and pancreas

2122

6996

1.92

151.62

4.1

3.6

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

582

765

3.88

151.51

3.7

3.1

—

Disorders of mineral metabolism

322

655

5.27

150.55

5.5

3.7

—

Headache

1215

4114

2.32

149.80

3.8

3.3

—

Diabetic nephropathy

683

2329

3.11

149.56

7.5

3.7

—

Complications of procedures, not elsewhere classified

1769

7282

1.99

148.58

4.5

3.5

—

STROKE

1046

2867

2.50

147.02

4.2

3.0

—

Alcohol use disorder, ICD-based

1051

4488

2.41

146.68

3.9

—

Implicit fungal Sepsis, including avohilmo

264

468

6.07

143.75

7.8

2.7

—

Haemorrhage from respiratory passages

835

2831

2.68

142.87

4.9

3.6

—

Mood disorders, excluding more controls

1871

5672

1.97

142.44

3.9

3.6

—

Sub-endpoint used in defining T1D endpoints

775

2857

2.75

142.20

5.8

3.7

—

Acute upper respiratory infections of multiple and unspecified sites

1650

6051

2.02

142.15

4.5

3.4

—

Ischaemic heart disease, wide definition

1612

4887

2.07

141.62

4.6

3.5

—

Myocardial infarction

1116

3355

2.38

141.32

5.2

3.4

—

Schizophrenia or delusion, excluding more controls

674

2323

2.94

141.11

3.9

3.6

—

Other general symptoms and signs

199

264

8.03

140.98

3.7

3.2

—

Other disorders of adrenal gland

214

315

7.53

140.94

5.4

3.6

—

ILD, hospital admissions 1, main diag only

487

1422

3.64

140.35

5.5

4.0

—

Retention of urine

954

3172

2.51

138.72

4.3

3.9

—

Used for control exclusion in common control thyroid runs

2110

5713

1.89

137.17

4.2

3.3

—

Adrenocortical insufficiency

185

239

8.71

137.04

5.4

3.6

—

Pain in limb

1813

6004

1.95

136.77

4.1

3.6

—

Genitourinary diseases

1112

2324

2.44

136.49

4.8

2.7

—

Symptoms and signs involving the digestive system and abdomen

1983

5249

1.92

135.21

4.0

3.6

—

Complications of medical and surgical care

1618

7510

1.97

134.63

4.5

3.6

—

Abnormal spermatozoa

461

1338

3.69

134.53

4.1

4.2

—

Diseases of the digestive system

1152

5257

2.23

134.44

5.0

3.7

—

Chronic nephritic syndrome

206

309

7.55

134.01

9.0

3.3

—

Any mental disorder

2134

5825

1.86

132.33

3.9

3.6

—

Suicide or other Intentional self-harm

606

2086

3.00

131.06

3.6

3.7

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

668

2421

2.84

130.98

3.5

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2095

6080

1.85

130.91

5.1

3.2

—

Explicit bacterial Sepsis

328

761

4.54

129.90

6.4

2.9

—

Bacterial pneumoniae

859

3062

2.52

129.87

5.5

2.9

—

Asthma (diagnoses ohter than nonallergic)

1857

8158

1.87

129.18

4.0

3.6

—

Care involving use of rehabilitation procedures

1252

5383

2.13

128.89

3.9

2.9

—

Glucagon-like peptide-1 (GLP-1) analogues

712

2692

2.72

128.75

3.9

3.8

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

712

2692

2.72

128.75

3.9

3.8

—

Explicit bacterial Sepsis, including avohilmo

330

776

4.47

128.41

6.3

2.9

—

Abdominal and pelvic pain

1954

5249

1.89

128.37

3.8

3.6

—

Endocrine disorders, other/unspecified

137

132

12.47

128.23

3.7

2.7

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

2093

7514

1.81

126.49

4.5

3.4

—

Hypertensive Heart Disease

560

1368

3.20

126.33

5.2

3.1

—

Other reaction to severe stress, and adjustment disorders

770

3045

2.58

126.32

4.5

3.4

—

Other functional intestinal disorders

1088

4527

2.23

125.78

4.2

3.6

—

Diagnoses used for exclusion with ILD

706

2697

2.71

125.63

4.3

3.8

—

Fungal Sepsis

186

267

7.67

125.15

8.6

2.7

—

Implicit fungal Sepsis

176

239

8.14

124.51

8.7

2.8

—

Peripheral artery disease

1105

4007

2.24

124.04

5.5

3.7

—

Fall on same level

2275

6913

1.78

123.94

4.0

3.6

—

Disorders of calcium metabolism

247

473

5.63

123.93

5.8

3.9

—

Problems related to lifestyle

307

705

4.56

123.07

4.6

3.2

—

Other diseases of urinary system

2000

6195

1.84

122.94

4.3

3.6

—

Disorders of lipoprotein metabolism and other lipidaemias

1596

5002

1.97

122.93

4.2

3.3

—

Hypothyroidism, drug reimbursement

211

203

7.42

122.58

4.5

2.1

—

Major coronary heart disease event excluding revascularizations

1282

4085

2.11

120.96

4.9

3.5

—

Hypertensive Renal Disease

173

238

8.00

120.93

7.9

3.0

—

Other soft tissue disorders, not elsewhere classified

1952

6120

1.84

120.83

3.9

3.6

—

Substance use, excluding alcohol

498

1622

3.18

118.82

4.4

3.7

—

Anxiety disorders, excluding more controls

1550

5137

1.95

118.52

4.1

3.6

—

AV-block

473

1249

3.35

118.22

4.7

3.2

—

Infections of the skin and subcutaneous tissue

1287

6369

2.03

117.66

5.2

3.6

—

Asthma/COPD (KELA code 203)

1874

6954

1.82

117.29

4.4

3.4

—

Intestinal infectious diseases, including avohilmo, including avohilmo

2299

7473

1.73

116.65

4.5

3.4

—

Personality disorders

598

2176

2.82

116.45

3.8

3.6

—

Exclusions for E4_PCOS_BROAD

480

1554

3.21

115.88

5.3

4.0

—

Use of hypnotics and sedatives

2131

6984

1.77

115.84

4.0

3.6

—

Mood [affective] disorders

2024

7379

1.78

115.69

3.9

3.7

—

Diseases of liver

843

3635

2.38

115.28

4.3

3.8

—

Mood disorders

2028

7392

1.78

115.27

3.9

3.7

—

Lung diseases due to external agents

462

1480

3.28

114.29

4.8

4.0

—

Other arrhythmias

1133

4019

2.14

114.12

3.7

3.0

—

Abnormalities of heart beat

738

2906

2.51

113.94

3.4

—

Vocal cord dysfunction

255

456

5.05

112.79

4.6

2.7

—

Osteopathies and chondropathies

1233

5650

2.03

112.42

4.9

3.5

—

Liquid cancers, including Hilmo

828

3133

2.39

111.37

4.2

3.9

—

Disorders of adult personality and behaviour

616

2329

2.71

111.29

3.5

—

Depression

1866

7034

1.80

111.18

3.8

3.6

—

Later onset COPD

795

2702

2.45

108.93

5.3

3.5

—

Other cataract

973

3306

2.24

108.52

5.0

3.5

—

Pain, not elsewhere classified

560

2044

2.80

108.13

4.0

3.4

—

Atherosclerosis, excluding cerebral and coronary sclerosis

1025

3792

2.18

107.91

5.4

3.7

—

Other pleural conditions

326

871

3.95

107.00

5.9

3.3

—

Unspecified haematuria

1030

3983

2.16

106.75

4.4

3.9

—

Disorders of lens

1346

4278

1.98

106.33

5.3

3.5

—

Intracranial injury

1296

6286

1.95

106.29

3.8

3.7

—

Injuries to the head

2215

7824

1.70

106.14

3.9

3.6

—

Other retinal disorders

1437

5817

1.91

105.94

4.8

3.7

—

Kela-code for severe mental illness

777

3362

2.37

105.12

4.1

3.6

—

Selective serotonin reuptake inhibitors

1897

5586

1.79

105.04

3.7

—

Insulin, fast-acting (human)

367

1073

3.55

104.64

6.1

3.3

—

Non-invasive ventilation

370

910

3.57

104.37

11.5

2.5

—

Other diseases of the digestive system

837

3758

2.29

104.21

5.1

3.7

—

Angina pectoris

1114

3603

2.09

102.67

4.3

3.4

—

Myocardial infarction, without ST-elevation

1010

4401

2.12

102.48

5.1

3.7

—

GI-bleeding

833

3769

2.27

101.74

5.1

3.7

—

Unspecified mental disorder

834

3767

2.26

101.69

4.0

3.7

—

Pneumonia due to other infectious organisms, not elsewhere classified

149

211

7.80

101.65

6.3

3.4

—

Streptococcal septicaemia

286

722

4.18

101.63

6.6

3.8

—

Symptoms and signs involving the nervous and musculoskeletal systems

1250

6560

1.94

101.33

4.0

3.7

—

Depression or dysthymia

1252

3438

2.02

100.77

3.9

3.7

—

Ulcer of lower limb, not elsewhere classified

448

1517

3.09

100.70

6.8

3.9

—

ILD medications: azathioprine

361

1075

3.48

99.95

7.0

2.9

—

Streptococcal septicaemia, including avohilmo

288

741

4.10

99.67

6.6

3.8

—

Certain infectious and parasitic diseases, including avohilmo

1274

3220

2.01

99.10

4.4

2.9

—

Disorders of choroid and retina

1681

6703

1.78

98.04

4.6

3.7

—

Diabetic retinopathy, excluding more controls

745

1732

2.50

97.03

5.6

3.3

—

Undetermined asthma, excluding more controls

252

594

4.36

97.02

4.1

2.5

—

Ill-defined and unknown causes of mortality

354

1071

3.51

96.68

5.1

4.1

—

Diseases of oesophagus, stomach and duodenum

2066

7319

1.69

96.17

4.2

3.5

—

Other ill-defined and unspecified causes of mortality

336

991

3.61

95.66

5.1

4.1

—

Emphysema

256

625

4.36

95.46

6.0

3.7

—

Disorders of parathyroid gland

516

1910

2.76

95.30

7.0

3.4

—

Schizophrenia, schizotypal and delusional disorders

679

2894

2.40

95.21

4.0

3.6

—

Cardiomyopathy

402

1317

3.15

94.93

5.1

3.1

—

Abnormal findings on diagnostic imaging of lung

1093

5302

1.99

94.77

5.1

3.7

—

Other diseases of intestines

1998

6622

1.70

94.69

4.1

3.5

—

Alcohol dependence

641

2682

2.46

94.03

4.1

3.9

—

Epilepsy

658

2776

2.42

93.59

4.0

3.7

—

Schizophrenia or delusion

674

2889

2.39

93.31

3.9

3.6

—

Myocardial infarction, strict

945

3199

2.13

93.18

5.2

3.4

—

Specific personality disorders

500

1866

2.75

92.85

3.5

3.6

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1265

6715

1.88

92.82

4.5

3.6

—

Azathioprine

361

1128

3.32

92.55

7.0

3.3

—

Psychiatric diseases

1766

5085

1.76

92.22

3.9

3.7

—

Anxiety disorders

1669

6611

1.75

92.21

4.1

3.6

—

Non-allergic asthma (mode), excluding more controls

319

914

3.54

91.65

4.8

2.6

—

Anxiety (asthma-related co-morbidities)

1055

4037

2.01

91.43

3.3

3.6

—

Viral hepatitis, IBD co-morbidity

122

153

8.29

91.18

4.4

2.9

—

Nephrotic syndrome

150

242

6.93

90.92

9.0

3.3

—

Acute peritonitis

240

581

4.44

90.87

9.7

4.0

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

726

3255

2.29

90.58

4.3

3.7

—

Pneumocystosis

118

148

9.38

90.50

6.6

4.0

—

Pneumocystosis, including avohilmo

118

148

9.38

90.50

6.6

4.0

—

Neurotic, stress-related and somatoform disorders

1645

6554

1.75

90.43

4.0

3.6

—

Asthma, including avohilmo

2271

7786

1.62

90.11

3.9

3.7

—

Acute alcohol intoxication, ICD10

504

1927

2.70

89.61

4.2

3.8

—

Other symptoms and signs involving the nervous and musculoskeletal systems

886

4309

2.10

89.53

4.1

3.7

—

Congenital malformations of the urinary system

208

455

4.91

89.49

8.6

4.1

—

Liquid cancers

667

2738

2.36

89.04

4.4

3.9

—

Drug-induced adrenocortical insufficiency

112

134

9.73

89.02

6.1

3.6

—

Dental caries

601

2349

2.48

88.90

6.7

3.6

—

Paralytic ileus and intestinal obstruction

642

2758

2.39

88.54

4.3

3.6

—

Other/unspecified cytomegaloviral diseases

111

132

9.70

88.48

10.4

3.0

—

Other or unspecified ileus, impaction or obstruction

498

1907

2.70

88.27

4.3

3.7

—

Other diseases of pericardium

160

282

6.10

87.84

5.9

3.3

—

Caries of dentine

548

2115

2.57

87.73

6.7

3.6

—

Other disorders of bladder

352

1124

3.28

87.59

3.8

4.0

—

Certain disorders involving the immune mechanism

468

1746

2.77

87.48

5.3

3.8

—

Osteoporosis

638

2516

2.40

86.96

4.8

3.6

—

Malignant neoplasm

1526

5068

1.79

86.84

3.7

—

Low back pain

1541

5971

1.76

86.79

4.0

3.6

—

Bacterial pneumonia, not elsewhere classified

733

2917

2.25

86.43

5.5

2.9

—

Bacterial pneumonia (organism specified)

992

4582

2.00

86.25

5.6

3.4

—

Iron deficiency anaemia secondary to blood loss (chronic)

433

1567

2.87

85.93

5.1

3.6

—

Cystic kidney disease

147

246

6.63

85.83

8.9

3.7

—

Recurrent or chronic depression

689

2069

2.35

85.64

3.0

3.6

—

Other endocrine disorders

185

360

5.28

85.61

4.2

4.1

—

Malignant neoplasm, wide definition

1552

5169

1.77

85.51

3.8

3.7

—

Hypothyroidism, strict autoimmune

1363

4966

1.82

85.34

4.1

3.3

—

Malignant neoplasm

1517

5061

1.78

85.01

3.7

—

Preparatory care for dialysis

185

386

5.26

84.86

8.8

3.9

—

Malignant neoplasm, including Hilmo

1547

5164

1.77

84.76

3.8

3.7

—

Acute alcohol intoxication

605

2584

2.40

84.74

4.4

3.9

—

Senile cataract

1206

3910

1.91

84.57

4.9

3.6

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

463

1751

2.74

84.27

3.4

3.9

—

Spondylosis

1163

4887

1.89

83.94

3.4

3.8

—

Other disorders involving the immune mechanism, not elsewhere classified

146

249

6.50

83.62

8.2

3.7

—

Autoimmune diseases related-to ILD

1609

7983

1.70

83.21

4.0

3.6

—

Idiopathic pulmonary fibrosis

275

784

3.74

82.61

5.9

4.0

—

Other anxiety disorders

852

3539

2.08

82.39

3.4

—

Cholelithiasis, broad definition with cholecystitis

1650

6519

1.71

82.19

3.8

3.6

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

213

507

4.43

81.92

3.7

3.3

—

Congenital malformations of the urinary system, including avohilmo

209

493

4.52

81.69

8.6

4.0

—

Acute upper respiratory infections

1971

7313

1.63

81.59

4.2

3.5

—

Delirium, not induced by alcohol and other psychoactive substances

394

1396

2.94

81.35

4.6

4.0

—

Polycystic kidney disease

126

191

7.39

81.13

8.6

3.5

—

Acidosis

112

150

8.46

80.73

7.9

3.2

—

Cytomegalovirus infection, IBD co-morbidity

116

162

8.09

80.59

10.1

3.3

—

Disorders of thyroid, IBD co-morbidities

264

464

3.96

80.13

3.3

2.7

—

Undetermined asthma

252

684

3.78

79.96

4.1

2.6

—

Cytomegaloviral disease, including avohilmo

118

170

7.80

79.64

9.9

3.2

—

Cardiomyopathies, Primary/intrinsic

295

897

3.42

79.25

4.8

3.3

—

Persons encountering health services for specific procedures, not carried out

231

598

4.03

79.07

4.6

3.0

—

Sequelae with surgical and medical care as external cause

508

2076

2.53

78.82

4.5

3.8

—

Cytomegaloviral disease

117

169

7.78

78.80

10.0

3.2

—

Cystic kidney disease, including avohilmo

147

267

6.05

78.71

8.9

3.9

—

Cardiomyopathy (excluding other)

303

941

3.34

78.65

4.7

3.3

—

Diseases of peritoneum

299

926

3.39

78.41

8.4

3.9

—

Cardiodefibrillation

831

4156

2.05

77.68

4.3

3.9

—

Cough

731

3245

2.14

77.14

3.9

3.5

—

Solid cancers, including Hilmo

1490

5064

1.73

76.86

3.7

—

Type of accident

658

3034

2.22

76.73

4.3

3.7

—

Intestinal stricture

715

3419

2.14

76.04

4.4

3.8

—

Asthma, hospital admissions , main diagnosis only

1563

8231

1.67

75.83

3.9

3.6

—

Emotionally unstable personality disorder

275

822

3.46

75.75

3.8

3.3

—

Fluid overload

45.07

75.64

13.1

3.1

—

Sequelae of external causes of morbidity and mortality

603

2702

2.29

75.64

4.6

3.8

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

135

236

6.33

75.42

8.5

3.6

—

Cholelithiasis

1566

6413

1.69

75.39

3.8

3.6

—

Falls/tendency to fall

1915

5955

1.63

75.33

3.9

3.6

—

Noninfective enteritis and colitis

929

4874

1.94

75.29

3.9

3.8

—

Gastrointestinal diseases

960

2422

2.01

75.27

4.0

2.8

—

Acute pancreatitis

463

1853

2.57

74.99

4.7

3.9

—

Non-allergic asthma (mode)

319

1042

3.10

74.12

4.8

2.7

—

Other pulmonary heart/vessel disease

173

381

4.90

74.06

6.9

4.0

—

Drug-induced neutropenia

221

585

4.01

73.86

3.9

4.0

—

Cystitis

1533

5429

1.70

73.76

4.1

3.5

—

Hypotension

495

2064

2.48

73.72

4.1

3.8

—

All anxiety disorders

1087

4623

1.85

73.48

3.3

3.5

—

Peripheral arterial reconstruction

467

1908

2.54

72.77

6.1

3.9

—

Cutaneous abscess, furuncle and carbuncle

566

2508

2.31

72.74

5.5

3.6

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1148

6501

1.79

72.40

4.5

3.6

—

Secondary right heart disease

159

333

5.17

72.37

7.1

4.0

—

Coagulation defects, purpura and other haemorrhagic conditions

465

1900

2.52

72.10

4.9

3.8

—

IgA nephropathy (IgA glomerulonephritis)

117

187

7.02

71.72

9.1

3.5

—

Other CVD

538

2354

2.36

71.69

4.1

3.8

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

1822

7677

1.60

71.61

3.7

—

Pneumonitis due to solids and liquids

272

843

3.40

71.42

5.0

4.0

—

Protozoal diseases

130

231

6.22

71.40

6.5

4.1

—

Solid cancers

1439

4978

1.71

71.36

3.7

—

Purpura and other haemorrhagic conditions

352

1264

2.89

71.03

4.5

3.9

—

Alcohol abuse, main dg, excluding more controls

330

1142

2.98

70.95

4.5

3.9

—

Protozoal diseases, including avohilmo

133

243

6.03

70.89

6.4

4.0

—

Other and unspecified nonorganic psychotic disorders

405

1560

2.66

70.82

3.7

—

Hyperparathyroidism

431

1705

2.58

69.81

7.6

3.4

—

ILD-related respiratory insufficiency

151

314

5.31

69.77

9.9

4.0

—

Dependence on enabling machines and devices, not elsewhere classified

14.08

69.72

10.0

2.6

—

Any event in cancer register

1574

5593

1.66

69.48

3.6

3.7

—

Second line medication for Crohn's disease

1076

6088

1.79

68.37

4.8

3.6

—

Abnormal results of function studies

243

724

3.51

67.73

4.9

3.8

—

Agranulocytosis

293

980

3.12

67.41

4.6

3.9

—

Other disorders of skin and subcutaneous tissue

1415

7263

1.67

67.38

5.1

3.6

—

L04AX Other immunosuppressants

1049

5921

1.80

67.35

4.9

3.6

—

Diabetic retinopathy, strict definition

542

2160

2.33

67.28

6.4

3.9

—

Finngen Rheumatological endpoints

1700

6032

1.62

66.98

4.1

3.4

—

Other noninfective gastroenteritis and colitis

539

2425

2.27

66.73

4.0

3.8

—

Viral and other specified intestinal infections, including avohilmo

537

2316

2.27

66.42

5.5

3.2

—

Chronic apical periodontitis

2030

7438

1.54

65.97

3.9

3.6

—

Other obstructive and reflux uropathy

128

239

5.67

65.91

5.1

2.6

—

Mental and behavioural disorders due to opioids

129

244

5.65

65.68

5.1

3.0

—

Dysphagia

528

2379

2.27

65.23

5.1

3.7

—

Cellulitis

498

2194

2.33

65.07

5.7

3.7

—

Viral and other specified intestinal infections

427

1710

2.49

64.93

6.2

3.2

—

Diseases of the myoneural junction and muscle

330

1203

2.85

64.89

4.3

4.0

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1678

6960

1.60

64.64

4.1

3.6

—

Thrombocytopenia, unspecified

226

669

3.57

63.96

4.9

3.9

—

Enlarged lymph nodes

308

1086

2.91

63.88

3.5

3.4

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

372

1402

2.65

63.69

6.6

3.9

—

All influenza (not pneumonia)

298

1035

2.96

63.60

5.7

3.1

—

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

537

1998

2.27

63.39

4.2

4.0

—

Symptoms and signs concerning food and fluid intake

243

753

3.33

63.05

4.9

3.6

—

Hypothyroidism, other/unspecified

1615

6711

1.60

62.78

4.1

3.6

—

Accidents

1385

4158

1.69

62.61

3.9

3.5

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

380

1515

2.60

62.47

4.2

4.1

—

Other external causes of accidental injury

1383

4158

1.68

62.18

3.9

3.5

—

Diabetic maculopathy

415

1635

2.52

61.89

6.3

3.9

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1766

7218

1.56

61.72

4.5

3.6

—

Chronic pancreatitis

311

1128

2.86

61.70

4.9

3.9

—

Other viral diseases

562

2646

2.16

61.47

6.4

3.5

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

115

208

5.89

61.41

6.9

2.8

—

Other diseases of liver

405

1677

2.48

61.07

4.4

3.8

—

Disorders of the thyroid gland

1723

7214

1.56

61.00

4.0

3.6

—

Tubulo-interstitial nephritis, not specified as acute or chronic

164

400

4.27

60.96

5.0

2.7

—

External causes of morbidity and mortality

1086

3069

1.79

60.77

3.9

3.5

—

Open wound of head

1103

6094

1.72

60.77

4.1

3.8

—

Acute pancreatitis (for exclusion)

463

2040

2.33

60.66

4.7

3.9

—

Cerebrovascular diseases

1417

6098

1.63

60.29

4.3

3.8

—

Ascites

210

615

3.58

60.26

3.9

4.0

—

Ischaemic Stroke, excluding all haemorrhages

1153

5013

1.72

60.18

4.0

3.9

—

Dorsalgia

1783

6109

1.56

60.04

3.6

—

Dermatitis

1200

7093

1.68

60.00

4.6

3.6

—

Stroke, excluding SAH

1202

5189

1.70

59.64

4.1

3.9

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

384

1519

2.52

59.64

6.4

3.9

—

Artificial opening status

163

409

4.22

58.71

6.5

3.8

—

Other disorders of glucose regulation and pancreatic internal secretion

231

730

3.30

58.63

5.8

3.8

—

Other and unspecified myopathies

251

835

3.15

58.51

4.0

4.1

—

Injuries to the thorax

951

5443

1.77

58.43

4.2

3.8

—

Other bacterial intestinal infections

417

1785

2.40

58.40

6.2

3.5

—

Mental and behavioural disorders due to sedatives or hypnotics

184

504

3.82

58.37

4.9

3.5

—

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

156

382

4.35

58.22

5.5

4.1

—

Chronic tubulo-interstitial nephritis

105

183

6.07

58.19

7.4

2.5

—

Neoplasms

1250

3913

1.69

58.04

4.0

3.5

—

Gastroduodenal ulcer

601

2973

2.06

57.96

4.8

3.8

—

Spondylopathies

1456

5390

1.61

57.78

3.6

3.7

—

Malignant neoplasm of urinary organs, including Hilmo

286

1034

2.87

57.12

4.6

4.0

—

Suppurative and necrotic conditions of lower respiratory tract

189

538

3.74

57.04

6.4

4.0

—

Stroke, including SAH

1238

5420

1.66

56.88

4.2

3.8

—

Emotional disorders starting during childhood or adolecense, excluding more controls

107

186

5.80

56.61

4.2

3.4

—

Malnutrition

163

6.58

56.47

4.9

4.1

—

Other infectious diseases, including avohilmo

249

846

3.07

55.88

5.3

3.9

—

Status epilepticus

124

262

5.06

55.73

6.0

3.5

—

Abnormal findings on examination of urine, without diagnosis

149

365

4.36

55.66

6.1

3.8

—

Failure and rejection of transplanted organs and tissues

9.22

55.58

10.5

3.2

—

Cardiac arrest

135

247

4.79

55.48

5.4

2.2

—

Non-selective monoamine reuptake inhibitors

659

3283

1.96

55.11

4.2

3.5

—

Urinary track infection

845

2275

1.88

55.09

4.0

2.7

—

Other and unspecified effects of external causes

521

2497

2.13

55.03

4.2

3.7

—

Hypercalcemia

151

378

4.28

54.87

5.3

4.2

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

226

737

3.19

54.35

4.2

3.6

—

Motor neuron disease (with DMD)

120

7.46

54.29

5.2

4.0

—

Isolated proteinuria with specified morphological lesion

10.42

53.87

8.3

3.0

—

Factors influencing health status and contact with health services

496

1103

2.29

53.72

4.0

2.7

—

Enterocolitis due to Clostridium difficile

283

1053

2.79

53.56

6.9

3.7

—

Pain (limb, back, neck, head abdominally)

1256

3833

1.66

53.54

3.9

3.7

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1468

6340

1.57

53.43

4.0

3.5

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

225

742

3.18

53.34

5.5

3.8

—

Other arthritis (FG)

587

2976

2.01

53.13

5.1

3.5

—

Other viral diseases, including avohilmo

674

3541

1.91

53.06

5.6

3.4

—

Malignant neoplasm of urinary organs

246

855

2.99

52.93

4.7

4.1

—

Respiratory conditions due to other external agents

150

6.65

52.87

4.3

3.7

—

Viral infections characterized by skin and mucous membrane lesions

797

4475

1.81

52.31

5.3

3.7

—

Pleural plaque

256

917

2.91

52.28

3.9

3.4

—

Other neurological diseases

1363

6758

1.58

52.24

3.9

3.8

—

Acute sinusitis

875

4568

1.76

52.22

4.1

3.4

—

Lower back pain or/and sciatica

1920

8139

1.48

52.02

3.8

3.6

—

Other infectious diseases

212

685

3.24

52.00

5.4

4.0

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

247

869

2.95

51.97

4.8

4.1

—

Unspecified fall

999

5873

1.69

51.93

4.2

3.8

—

Statin medication

1089

3652

1.70

51.88

4.5

3.1

—

Motor neuron disease ALS

117

7.37

51.75

5.1

3.8

—

Diseases of pulp and periapical tissues, including avohilmo

1816

6293

1.50

51.73

3.7

—

Malignant neoplasm of respiratory system and intrathoracic organs

468

1808

2.20

51.61

4.0

—

Endocarditis

109

220

5.26

51.60

5.7

2.9

—

Pneumonia due to Haemophilus influenzae

22.92

51.58

6.7

2.2

—

Primary_lymphoid and hematopoietic malignant neoplasms

529

2620

2.07

51.49

4.6

3.9

—

Presbycusis

379

1626

2.37

51.45

3.7

3.9

—

Malignant neoplasm of bronchus and lung, including Hilmo

466

1813

2.19

51.25

4.2

4.0

—

Other diseases of pancreas

221

738

3.12

51.18

4.6

4.1

—

Calcific aortic valvular stenosis, including rheumatic fever

688

3584

1.89

50.97

4.7

3.8

—

Diseases of the skin and subcutaneous tissue

1700

5648

1.52

50.89

4.1

3.3

—

Bipolar affective disorders

333

1369

2.48

50.85

3.7

3.6

—

Other specified and unspecified personality disorders

204

651

3.25

50.84

4.4

3.4

—

Calcific aortic valvular stenosis, operated

687

3585

1.89

50.81

4.7

3.8

—

Calcific aortic valvular stenosis

687

3585

1.89

50.81

4.7

3.8

—

Operations 2 for CAVS

686

3579

1.89

50.76

4.7

3.8

—

Calcific aortic valvular stenosis, diagnosis (helper)

686

3579

1.89

50.76

4.7

3.8

—

Amputation

270

1009

2.78

50.72

7.8

4.0

—

Other and unspecified dermatitis

974

5836

1.69

50.71

4.7

3.6

—

Mixed and other personality disorders

184

554

3.45

50.45

4.2

3.3

—

Disorders of magnesium metabolism

12.91

50.02

3.9

3.6

—

Hernia of abdominal wall

884

5186

1.73

50.00

4.7

3.8

—

Elevated blood glucose level

224

768

3.04

49.51

5.8

4.0

—

Obesity, other/unspecified

567

2910

1.98

49.48

3.9

3.3

—

Hypocalcemia

185

5.75

49.42

6.0

3.7

—

Congenital malformations, deformations and chromosomal abnormalities

978

5585

1.68

49.31

5.0

3.4

—

Clear cell adenocarcinoma of kidney

142

368

4.09

49.09

4.1

4.0

—

Malignant neoplasm of kidney, except renal pelvis

224

772

3.02

49.00

4.7

4.2

—

Leisure time condition

396

1788

2.27

49.00

4.3

3.9

—

Peripheral artery operations in Hilmo

311

1266

2.53

48.87

7.3

3.7

—

Nonorganic sleeping disorders, excluding more controls

346

1473

2.39

48.83

3.6

3.5

—

Malignant neoplasm of digestive organs, including Hilmo

781

3228

1.80

48.56

3.7

4.0

—

Pure hypercholesterolaemia

1199

4763

1.61

48.46

4.0

3.4

—

Other and unspecified drugs and medicaments

217

740

3.05

48.41

4.0

3.8

—

Other/unspecified dorsalgia

702

3845

1.83

48.07

3.9

3.7

—

Bacterial intestinal infections, IBD co-morbidities

411

1902

2.22

47.89

6.3

3.7

—

Hyperkinetic disorders, excluding more controls

193

569

3.22

47.65

3.2

—

Migraine

704

3006

1.84

47.61

3.2

3.5

—

Pneumonia due to Streptococcus pneumoniae

112

248

4.75

47.38

5.2

3.4

—

Pyothorax

151

420

3.84

47.35

6.8

4.1

—

Other specified/unspecified arthritis

519

2628

2.01

47.26

5.2

3.6

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

797

4547

1.75

47.17

4.2

3.7

—

Gout due to impairment of renal function

8.75

46.78

8.6

2.9

—

Gastro-oesophageal reflux disease

1215

6571

1.58

46.64

3.9

3.6

—

Diseases of the eye and adnexa

1279

4059

1.59

46.64

4.1

3.3

—

Osteoporosis with pathological fracture (FG)

189

609

3.24

46.57

4.6

3.3

—

Eosinophilic disease (BM)

9.57

46.49

5.8

2.9

—

Schizophrenia

317

1331

2.44

46.44

4.6

3.8

—

Vitreous haemorrhage

257

985

2.71

46.01

5.9

4.1

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

170

518

3.42

45.87

4.5

3.7

—

Secondary polycythaemia

194

5.39

45.80

4.2

3.9

—

Other metabolic disorders

248

932

2.73

45.78

4.0

3.2

—

Diabetic retinopathy

910

3358

1.72

45.72

5.3

4.1

—

Sulfonylureas

681

2991

1.84

45.64

4.6

3.8

—

Aortic aneurysm

518

2604

1.99

45.59

4.1

3.7

—

Other disorders of white blood cells

154

444

3.65

45.52

5.3

4.0

—

Malignant neoplasm of digestive organs

719

3084

1.81

45.48

3.6

3.9

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

361

1391

2.30

45.46

3.4

3.3

—

Charcot foot

102

7.39

45.32

10.0

3.5

—

Nonischemic cardiomyopathy

225

810

2.87

45.26

5.0

3.8

—

Isolated proteinuria

100

211

5.11

45.23

6.3

3.2

—

Alcohol abuse, main dg

330

1441

2.35

44.30

4.5

4.0

—

Cerebral cysts

159

476

3.50

44.25

3.7

—

Valvular operations

269

1074

2.57

43.93

5.2

3.2

—

Other bacterial intestinal infections, including avohilmo

466

2334

2.04

43.89

5.9

3.5

—

Focal epilepsy

430

2095

2.10

43.72

3.9

4.0

—

Other complications of surgical and medical care, not elsewhere classified

218

787

2.86

43.70

4.6

3.5

—

Malignant neoplasm of bladder, including Hilmo

286

1166

2.50

43.56

3.8

3.9

—

Alcoholic liver disease

249

968

2.67

43.35

4.3

4.2

—

Secondary uncertain malignant neoplasm

294

1233

2.45

43.34

4.0

3.8

—

Dizziness and giddiness

1328

6845

1.52

43.30

3.6

3.8

—

Other sleep disorders

227

840

2.78

43.28

3.5

3.8

—

Non-small cell lung cancer, including Hilmo

337

1401

2.32

43.20

4.2

3.9

—

Postviral fatigue syndrome

12.77

43.07

1.3

2.2

—

Collagenous colitis

217

789

2.85

43.02

3.9

—

Abnormal findings on examination of blood, without diagnosis

948

5316

1.64

42.84

4.9

3.9

—

Protein-energy malnutrition of moderate and mild degree

9.39

42.62

4.9

4.4

—

Systemic connective tissue disorders

648

3656

1.80

42.20

4.2

3.6

—

Intestinal malabsorption

127

340

3.93

41.86

4.7

3.6

—

Cardiomyopathy, other and unspecified

164

521

3.26

41.27

5.9

3.3

—

KRA_PSY_EATING, excluding more controls

132

360

3.71

41.18

3.4

2.8

—

Arthropathies in other diseases classified elsewhere

112

278

4.27

41.14

7.4

3.5

—

Post-traumatic stress disorder

160

502

3.27

40.93

3.2

3.1

—

Other diseases of biliary tract

207

755

2.84

40.82

4.6

3.9

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

314

1391

2.32

40.80

3.9

—

Other symptoms and signs involving the digestive system and abdomen

296

1278

2.36

40.65

4.3

3.6

—

Diseases of the musculoskeletal system and connective tissue

870

2597

1.70

40.60

4.0

3.2

—

145

5.74

40.59

3.4

—

Combinations of oral blood glucose lowering drugs

515

2745

1.91

40.43

3.6

3.8

—

Reimbursement for rheumatic diseases

968

6090

1.60

40.42

4.1

3.6

—

Haemorrhage, not elsewhere classified

107

260

4.33

40.29

6.8

3.6

—

Duodenal ulcer

265

1099

2.49

40.19

5.3

3.9

—

Hypoglycaemia, other or unspecified

173

578

3.11

40.11

5.1

4.0

—

Unspecified acute lower respiratory infection

318

1427

2.28

40.03

5.7

3.7

—

Idiopathic gout

246

990

2.58

39.99

6.2

4.0

—

Cirrhosis of liver, NAS

155

488

3.34

39.95

4.5

—

Soft tissue disorders

1725

6168

1.44

39.95

3.7

3.6

—

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

1039

6098

1.57

39.56

4.9

3.4

—

Ventral hernia

477

2501

1.94

39.45

4.9

3.8

—

Nerve, nerve root and plexus disorders

1836

7851

1.41

39.39

3.8

3.7

—

Malignant neoplasm of bronchus and lung

397

1615

2.10

39.34

4.1

3.9

—

Phlebitis and thrombophlebitis (not including DVT)

427

2162

2.01

39.09

5.0

3.7

—

Polyneuropathies and other disorders of the peripheral nervous system

455

2365

1.97

38.73

5.5

3.9

—

Focal epilepsy, strict definition

396

1962

2.06

38.57

3.9

4.0

—

Noninfectious colitis NAS

285

1242

2.35

38.52

4.3

3.8

—

Neuromuscular dysfunction of bladder

201

744

2.79

38.51

4.8

4.0

—

Other specified disorders of kidney and ureter

101

246

4.37

38.13

7.1

3.4

—

Type 1 diabetes, definitions combined

171

580

3.01

38.09

4.1

3.6

—

Dental pulpitis, including avohilmo

1480

6547

1.46

37.98

3.4

3.8

—

Schizoaffective disorder

164

548

3.10

37.93

4.1

3.6

—

Traumatic subdural haemorrhage

281

1139

2.36

37.92

4.4

3.8

—

Fentanyl

226

893

2.59

37.72

5.2

3.6

—

Fracture of rib(s), sternum and thoracic spine

620

3578

1.76

37.49

3.9

3.7

—

Other headache syndromes

604

3439

1.77

37.47

3.7

3.5

—

Unstable angina pectoris

661

3015

1.75

37.46

4.4

3.5

—

Alcohol-induced chronic pancreatitis

167

570

3.06

37.45

4.7

4.2

—

Other diseases of blood and blood-forming organs

175

614

2.97

37.28

4.6

3.9

—

Other systemic involvement of connective tissue (FG)

450

2312

1.94

37.17

3.7

3.6

—

Mouth breathing

701

4183

1.70

37.17

3.8

4.0

—

Type 1 diabetes, strict (exclude DM2)

170

583

2.98

37.15

4.1

3.8

—

Hypoparathyroidism

102

256

4.21

36.92

4.5

3.4

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

375

1854

2.07

36.78

4.0

3.9

—

Any operation in hilmo

21.21

36.74

2.3

1.4

—

Fibrosis and cirrhosis of liver

190

706

2.80

36.31

4.5

4.2

—

Malignant neoplasm of bladder

178

640

2.88

36.12

4.1

3.9

—

Exclusions for E4_PCOS_CONSORTIUM

1087

4452

1.54

35.78

3.8

3.5

—

Vascular disorders of the intestines

182

668

2.83

35.61

4.6

3.8

—

Abnormal findings on diagnostic imaging of other body structures

281

1261

2.28

35.46

4.2

3.6

—

Lyme disease, including avohilmo

117

3559

0.32

35.43

3.1

3.8

—

Lyme disease

117

3559

0.32

35.43

3.1

3.8

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

917

4556

1.58

35.26

4.0

3.4

—

Amputation of toe

191

724

2.75

35.21

8.1

4.0

—

Other spirochaetal diseases

120

3591

0.33

35.17

3.1

3.8

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

434

2262

1.92

35.05

4.6

3.4

—

Spirochaetal infections, other/unspecified, including avohilmo

120

3583

0.33

35.01

3.1

3.8

—

Unspecified contracted kidney

12.53

34.95

9.8

2.8

—

Emotional disorders and disorders of social functioning with onset specific to childhood

114

312

3.70

34.93

4.3

3.8

—

Presence of cardiac and vascular implants and grafts

756

3400

1.66

34.85

4.3

3.7

—

Cholangitis (primary sclerosing, PSC)

155

528

3.05

34.81

4.8

3.8

—

Benign intracranial hypertension

9.81

34.79

3.4

2.0

—

Other and unspecified tonsillitis

504

2299

1.84

34.78

3.8

3.2

—

Hypopituitarism

164

576

2.95

34.75

4.9

3.7

—

Diverticular disease of intestine

1209

5087

1.49

34.65

4.3

3.7

—

Attention to artificial openings

112

314

3.74

34.60

7.0

3.2

—

Other spirochaetal diseases, including avohilmo

125

3636

0.34

34.57

3.1

3.8

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

176

4.79

34.26

4.0

3.0

—

Open wound of lower leg

311

1474

2.16

34.24

4.6

3.9

—

Injury, poisoning and certain other consequences of external causes

818

2516

1.64

34.15

3.9

3.5

—

Sensorineural hearing loss

1323

6110

1.46

33.87

3.9

—

Other and unspecified polyneuropathies, also in other diseases

397

2069

1.96

33.65

5.8

3.9

—

Inflammatory bowel disease

538

3075

1.77

33.60

3.6

3.7

—

Acute and transient psychotic disorders

221

917

2.47

33.44

4.4

3.7

—

Injuries to the hip and thigh

916

5351

1.55

33.37

4.0

3.8

—

Other embolism and thrombosis

259

1158

2.29

33.06

4.8

3.8

—

Pleural plaque with presence of asbestos

205

833

2.57

32.92

3.9

4.2

—

Fibromyalgia

163

588

2.84

32.73

3.0

—

Non-Hodgkin lymphoma, all, including Hilmo

258

1157

2.29

32.70

3.9

4.0

—

Mycoses

510

2898

1.79

32.60

5.7

3.7

—

Gastric ulcer

368

1889

1.99

32.57

4.5

3.8

—

Nonalcoholic fatty liver disease

203

821

2.54

32.54

3.4

3.9

—

Ulcerative ileocolitis

102

280

3.82

32.50

3.7

3.8

—

Osteomyelitis

166

611

2.83

32.41

7.5

4.0

—

Internal derangement of knee

631

3764

1.68

32.37

4.1

3.5

—

Cholecystectomy

1185

6948

1.46

32.14

3.7

—

Dissociative [conversion] disorders

228

4.11

32.03

3.1

2.8

—

Other viral diseases, not elsewhere classified

329

1628

2.05

31.91

6.5

3.6

—

Myocarditis

181

4.49

31.89

5.8

2.2

—

Drug-induced hypoglycaemia without coma

103

6.09

31.85

7.1

3.9

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

8.58

31.72

8.5

2.4

—

Other hearing loss

566

3229

1.72

31.71

4.1

3.8

—

Other symptoms and signs involving the circulatory and respiratory systems

137

458

3.08

31.68

4.5

3.6

—

Drug-induced osteoporosis with pathological fracture

111

5.88

31.63

5.6

4.0

—

Other gastritis (incl. Duodenitis)

418

2263

1.88

31.43

4.5

3.7

—

Injuries to the ankle and foot

1154

6798

1.46

31.43

3.8

3.7

—

Molar incisor enamel hypoplasia, with caries

9.66

31.38

15.8

4.0

—

Poisoning by narcotics and psychodysleptics [hallucinogens]

6.28

31.36

5.1

2.8

—

Dermatitis and eczema

1873

8227

1.36

31.30

4.3

3.6

—

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

7.10

31.18

6.1

2.8

—

Other blood glucose lowering drugs, excl. Insulins

295

1423

2.12

31.08

5.0

3.7

—

Organic, including symptomatic, mental disorders

977

4578

1.52

30.99

3.8

3.9

—

Non-small cell lung cancer

233

1013

2.33

30.92

4.3

3.9

—

Carrier of infectious disease

167

4.70

30.83

6.3

3.0

—

Other condition

281

1335

2.15

30.82

4.3

3.8

—

Use of disulfiram, acamprosate or naltrexone

182

722

2.60

30.47

3.6

4.0

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

203

845

2.45

30.46

4.2

3.2

—

Other viral diseases, not elsewhere classified, including avohilmo

432

2368

1.84

30.42

5.5

3.5

—

Other degenerative diseases of the nervous system

440

1750

1.86

30.35

3.5

3.7

—

Simple and mucopurulent chronic bronchitis

103

298

3.60

30.32

5.7

4.3

—

Adverse effects, not elsewhere classified

341

1747

1.99

30.29

4.2

3.7

—

Other and unspecified vasculitis limited to skin

183

4.50

30.14

6.0

3.5

—

Phobic anxiety disorders

209

883

2.40

30.09

2.8

3.3

—

Conductive and sensorineural hearing loss

1350

6369

1.42

30.09

3.9

—

Decubitus ulcer and pressure area

163

618

2.74

30.08

6.5

3.7

—

Emotional disorders starting during childhood or adolescence

109

326

3.43

29.86

4.3

3.9

—

Other dorsopathies, not elsewhere classified

1620

6130

1.38

29.67

3.7

3.6

—

Rheumatoid arthritis

535

2786

1.72

29.63

4.1

3.5

—

Infective dermatitis

232

1039

2.29

29.58

4.9

3.7

—

Hypoplasia of dental enamel

8.33

29.32

16.9

6.0

—

Childhood asthma (age<16), excluding more controls

163

472

2.73

29.19

3.4

2.4

—

Dilated cardiomyopathy

259

1222

2.18

29.13

4.3

4.2

—

Type 1 diabetes, strict definition, subgroup 1

125

415

3.08

29.08

3.6

—

Candidiasis

266

1266

2.15

29.05

6.0

3.6

—

Non-small cell lung cancer, adenocarcinoma

146

532

2.84

29.05

4.2

—

Hernia

1516

7353

1.38

28.77

4.0

3.7

—

Arterial embolism and thrombosis

143

520

2.85

28.55

5.5

3.9

—

Other disorders of ear

1512

7133

1.38

28.55

4.0

3.8

—

Personal history of certain other diseases

6.20

28.53

3.8

1.9

—

Diseases of the ear and mastoid process

1835

6870

1.35

28.43

3.9

3.6

—

Candidiasis, including avohilmo

502

2952

1.72

28.43

4.9

3.6

—

Mental and behavioural disorders due to cannabinoids

183

4.28

28.16

3.4

3.2

—

Migraine without aura

250

1172

2.16

28.15

3.6

3.3

—

Unspecified nephritic syndrome

163

4.59

28.14

8.2

3.2

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

1492

8521

1.37

28.14

4.3

3.6

—

Amputation of ankle bones

198

4.23

28.07

10.9

3.6

—

Crohn disease

234

1075

2.22

27.98

3.0

3.9

—

Type 1 diabetes, strict definition

129

447

2.94

27.81

4.0

3.5

—

Meniscus derangement

908

4033

1.51

27.79

3.6

3.5

—

Vasculitis limited to skin, not elsewhere classified

199

4.16

27.75

5.9

3.6

—

Other diseases of intestine

297

1498

2.02

27.73

4.8

3.7

—

Ulcerative colitis

410

2294

1.81

27.69

3.8

—

Eosinophilia

114

5.41

27.59

5.8

3.8

—

Iron deficiency

179

4.25

27.20

2.2

2.7

—

Childhood asthma (age<16)

163

490

2.63

27.19

3.4

2.5

—

Pericarditis

219

3.90

27.19

7.2

2.9

—

Alcohol withdrawal state with delirium

161

640

2.61

27.03

3.5

4.2

—

Secondary and unspecified malignant neoplasm of lymph nodes

169

686

2.53

27.00

4.6

4.0

—

Thiazolidinediones

219

998

2.25

26.85

4.6

3.9

—

Multiple myeloma, including Hilmo

113

375

3.15

26.75

4.9

4.0

—

Superficial injury of lower leg

440

2539

1.76

26.72

4.4

3.7

—

Sulfasalazine

415

2354

1.78

26.70

4.1

3.2

—

Other diseases of oesophagus

201

886

2.33

26.70

4.1

3.8

—

Folate deficiency anaemia

6.96

26.64

4.8

3.6

—

Psychotic depression

110

359

3.15

26.55

4.0

3.8

—

Immunodeficiencies

106

340

3.24

26.52

6.4

3.9

—

Abdominal aortic aneurysm (AAA)

229

1062

2.19

26.31

4.6

3.9

—

Mental retardation, excluding more controls

220

3.78

26.16

4.9

5.0

—

Vitamin deficiency

108

353

3.17

26.15

5.0

3.4

—

Vitamin deficiency, wide

108

353

3.17

26.15

5.0

3.4

—

Primary adrenocortical insufficiency

6.95

26.13

4.8

2.8

—

Misadventures to patients during surgical and medical care

268

1332

2.05

26.13

5.0

3.6

—

Arthropathies

1406

5162

1.38

26.13

4.2

3.4

—

Assault

229

1072

2.18

26.12

4.6

3.6

—

L01XE Protein kinase inhibitors

126

451

2.91

26.08

4.9

4.1

—

Intentional self-harm by sharp object

151

4.51

26.06

3.2

2.3

—

Continuous positive airway pressure

196

705

2.34

26.01

4.4

2.8

—

Bronchiectasis

158

633

2.57

26.00

5.7

3.6

—

Secondary malignant neoplasm of other and unspecified sites

132

4.88

25.95

3.5

3.8

—

Thoracic aortic aneurysm

284

1448

2.01

25.84

3.9

3.8

—

Missing teeth due to accident, extraction or parodontitis

1054

6646

1.43

25.70

4.2

3.8

—

Systemic atrophies primarily affecting the central nervous system

112

379

3.09

25.70

4.8

4.1

—

Other diseases of anus and rectum

532

3253

1.65

25.62

3.8

3.6

—

Symptoms and signs involving appearance and behaviour

7.87

25.54

4.6

2.5

—

Injuries to the knee and lower leg

1940

8043

1.31

25.47

3.9

3.6

—

Crohn's disease NAS

132

489

2.78

25.44

3.0

3.8

—

Allergic asthma (mode), excluding more controls

241

1131

2.10

25.29

3.0

2.4

—

Panic disorder

218

1014

2.18

25.21

3.3

3.4

—

Unspecified jaundice

114

393

3.00

25.17

4.2

4.3

—

Primary Sclerosing Cholangitis, IBD and UDCA required

139

4.64

25.14

5.5

3.8

—

Pneumothorax

144

561

2.64

25.13

5.5

3.4

—

Oesophageal varices

105

347

3.16

25.09

4.9

4.3

—

Acute pharyngitis

238

1135

2.11

25.09

3.5

3.4

—

Caries of dentine, including avohilmo

1280

4721

1.40

24.95

3.8

3.9

—

Use of pramipexole

392

2241

1.78

24.77

4.4

3.8

—

Chronic viral hepatitis

109

370

3.04

24.72

4.6

3.3

—

Ulcerative colitis, NAS

243

1191

2.08

24.62

4.0

3.9

—

Diffuse large B-cell lymphoma

114

399

2.97

24.57

4.1

4.0

—

Diffuse large B-cell lymphoma, helper endpoint

114

399

2.97

24.57

4.1

4.0

—

Diffuse large B-cell lymphoma, including Hilmo

114

399

2.97

24.57

4.1

4.0

—

Methotrexate

220

1040

2.15

24.49

3.2

3.3

—

Other and unspecified disorders of white blood cells

322

3.21

24.31

5.0

3.8

—

Migraine with aura

308

1640

1.90

24.31

3.1

3.4

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

531

3310

1.62

24.06

4.1

3.7

—

Non-Hodgkin lymphoma, all

109

377

3.01

24.02

3.5

4.2

—

Fracture of lumbar spine and pelvis

425

2500

1.72

24.02

4.2

3.9

—

Disorders of plasma-protein metabolism, not elsewhere classified

10.31

23.95

2.3

2.9

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

196

898

2.24

23.79

4.3

3.8

—

Coronary artery bypass grafting

445

1948

1.72

23.79

4.7

3.5

—

Disorders of refraction and accommodation

436

2582

1.70

23.77

4.8

3.7

—

Dorsopathies

1612

6151

1.33

23.75

3.7

—

Other systemic involvement of connective tissue

457

2757

1.68

23.66

3.6

3.7

—

Intestinal adhesions without obstruction

175

767

2.34

23.63

4.0

—

Pyogenic arthritis

140

555

2.60

23.59

5.6

3.6

—

FESS (DNB20)

220

1057

2.12

23.57

4.0

3.6

—

Malignant neoplasm of skin

764

3468

1.50

23.36

3.6

3.9

—

Zoster [herpes zoster]

341

1907

1.82

23.27

5.3

3.8

—

Amyloidosis

166

4.14

23.14

6.5

3.7

—

Postmenopausal osteoporosis with pathological fracture

136

538

2.61

23.09

4.3

3.5

—

Maltreatment syndromes

105

363

2.98

23.05

3.7

2.8

—

Necrosis of pulp, including avohilmo

894

6196

1.44

22.95

3.5

3.7

—

Nonorganic sleeping disorders

346

1950

1.80

22.92

3.6

—

Radiculopathy

295

1588

1.89

22.79

4.0

3.7

—

Persistent mood disorders

301

1629

1.87

22.78

4.6

3.6

—

Gingival hyperplasia

293

3.24

22.76

9.2

4.2

—

Other joint disorders

1338

5155

1.36

22.64

3.6

3.4

—

Left bundle-branch block

128

496

2.64

22.55

3.3

—

Somnolence, stupor and coma

107

380

2.92

22.49

6.0

3.7

—

Fracture of shoulder and upper arm

614

4015

1.54

22.47

4.2

3.8

—

Mixed disorders of conduct and emotions, excluding more controls

5.49

22.46

4.6

3.9

—

Fracture of foot, except ankle

392

2302

1.72

22.46

4.3

3.8

—

Malignant neoplasm of skin, including Hilmo

790

3601

1.48

22.45

4.0

3.9

—

Sarcoidosis

234

1172

2.04

22.44

3.2

3.9

—

Necrotizing fasciitis

9.66

22.43

5.1

3.9

—

Arterial embolism and thrombosis of lower extremity artery

301

3.19

22.39

4.6

3.8

—

Multiple myeloma and malignant plasma cell neoplasms

119

449

2.76

22.36

4.8

4.2

—

Vascular diseases of the intestine

333

3.06

22.32

3.7

3.9

—

Degeneration of macula and posterior pole

845

4530

1.45

22.20

3.8

—

Open wound of ankle and foot

201

957

2.15

22.12

4.4

4.0

—

Irritable bowel syndrome

404

2401

1.70

22.11

3.2

3.5

—

Ethmoidectomy

224

1111

2.06

22.06

3.9

3.6

—

Renal agenesis and other reduction defects of kidney

9.58

22.01

10.3

3.4

—

Hyperfunction of pituitary gland

298

3.15

21.98

5.1

2.6

—

Toxic effect of other and unspecified substances

6.02

21.97

4.6

3.2

—

Diseases of pulp and periapical tissues and dental caries

1060

3886

1.41

21.93

3.9

3.8

—

Other necrotizing vasculopathies (FG)

127

500

2.62

21.80

5.8

3.3

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

731

4947

1.48

21.74

4.4

3.6

—

5-aminosalicylic acid

305

1682

1.84

21.71

3.3

—

Fracture of femur

518

2960

1.60

21.65

4.2

3.8

—

Hyperaldosteronism

217

3.59

21.57

4.7

3.7

—

Injuries to the shoulder and upper arm

1404

8204

1.33

21.57

3.9

3.8

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

702

3198

1.50

21.47

3.7

3.9

—

ILD medications: nintedanib

8.20

21.45

8.5

2.8

—

Abnormalities of gait and mobility

243

1255

1.98

21.43

3.8

4.3

—

Zoster [herpes zoster], including avohilmo

844

5727

1.43

21.41

4.3

3.6

—

Viral pneumonia (known virus, not influenza)

223

3.53

21.39

7.5

3.9

—

Colorectal cancer, including Hilmo

438

2496

1.66

21.34

3.6

3.9

—

Dental caries, including avohilmo

1180

4422

1.38

21.21

3.8

—

Glaucoma

954

5814

1.41

21.18

3.9

3.8

—

Other viral hepatitis, including avohilmo

123

483

2.61

21.17

4.4

3.5

—

Wide developmental disorders, excluding more controls

136

4.21

21.16

2.7

4.1

—

Gonarthrosis [arthrosis of knee](FG)

1150

4844

1.37

21.12

3.6

3.5

—

DVT of lower extremities

328

1867

1.78

21.12

4.8

3.7

—

Other necrotizing vasculopathies

151

657

2.37

20.88

5.8

4.1

—

Fitting and adjustment of external prosthetic device

19.20

20.86

13.8

1.7

—

Viral warts

179

834

2.19

20.84

6.8

3.7

—

Other viral hepatitis

118

458

2.65

20.81

4.5

3.4

—

Hepatic failure, not elsewhere classified

321

3.02

20.67

3.7

4.2

—

Urolithiasis

568

3733

1.54

20.58

3.8

3.9

—

Other disorders starting during childhood or adolecense, excluding more controls

206

3.46

20.48

5.1

3.4

—

Other renal tubulo-interstitial diseases

127

4.35

20.46

6.7

2.2

—

Weight loss

202

994

2.08

20.45

4.2

4.0

—

559

3135

1.55

20.44

3.9

3.8

—

Superficial injury of thorax

271

1474

1.87

20.33

4.2

3.9

—

Somatoform disorder

250

1324

1.92

20.32

4.1

3.6

—

Postprocedural disorders of digestive system, not elsewhere classified

236

3.35

20.18

6.1

3.7

—

Alcohol-induced acute pancreatitis

304

3.06

20.17

4.2

4.1

—

Umbilical hernia

467

2951

1.60

20.16

4.6

3.9

—

Generalized anxiety disorder

221

1123

1.99

20.14

2.7

3.3

—

Dental operations

981

3615

1.41

20.11

3.8

3.6

—

415

2375

1.66

20.11

4.0

3.8

—

Secondary thrombocytopenia

5.33

20.10

5.0

4.1

—

Other abnormalities of plasma proteins

130

4.37

20.06

6.5

3.1

—

Benign neoplasms

1566

6568

1.30

20.03

4.0

3.6

—

Urticaria and erythema

534

3479

1.55

20.03

4.1

3.7

—

Panhypopituitarism

130

4.34

20.00

3.2

3.6

—

Gonarthrosis

999

4074

1.39

19.98

3.7

3.5

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

177

836

2.16

19.95

6.5

4.4

—

Pneumonia derived septicemia

285

3.11

19.89

6.5

3.8

—

Allergic asthma (mode)

241

1235

1.92

19.87

3.0

2.5

—

Hypertrophy of (infrapatellar) fat pad

6.44

19.85

4.3

2.6

—

Eating disorder

134

563

2.42

19.80

3.4

2.9

—

Total colectomy

323

2.95

19.80

4.9

3.6

—

Total colectomy operation

323

2.95

19.80

4.9

3.6

—

Infection due to other mycobacteria

106

4.71

19.72

6.0

3.7

—

Periapical abscess

718

4985

1.45

19.70

3.8

—

Autism spe, excluding more controls

4.78

19.69

2.0

3.7

—

Other Crohn's disease

124

507

2.51

19.63

3.0

3.4

—

Syndrome of inappropriate secretion of antidiuretic hormone

8.49

19.58

3.7

2.6

—

Superficial injury of hip and thigh

285

1595

1.82

19.48

4.3

3.7

—

Other eating disorders

292

3.02

19.48

3.8

3.0

—

Cholecystitis

252

1359

1.89

19.45

4.3

3.9

—

Unspecified chronic bronchitis

253

3.19

19.24

4.8

4.0

—

Chronic ulcer of skin, not elsewhere classified

144

636

2.33

19.24

6.4

3.7

—

Renal agenesis and other reduction defects of kidney, including avohilmo

7.69

19.23

10.0

3.1

—

Amyloidosis, other/unspecified

134

4.19

19.20

7.3

3.4

—

Fracture of lower leg, including ankle

858

6059

1.40

19.16

4.4

3.7

—

Polyarthrosis

333

1756

1.73

19.07

3.9

3.6

—

Superficial injury of abdomen, lower back and pelvis

268

1482

1.84

19.07

4.1

3.7

—

Lung transplant status

6.69

19.03

11.5

4.9

—

Lung transplantation

6.68

19.02

11.5

4.9

—

Intentional self-harm by unspecified means

5.59

18.98

4.8

2.4

—

Abscess of lung

118

4.43

18.97

6.8

3.5

—

Other and unspecified mood [affective] disorders

112

443

2.58

18.96

3.4

3.2

—

Rheumatism, unspecified

201

1013

2.02

18.96

3.6

3.5

—

Other aneurysm

120

493

2.51

18.92

5.7

3.9

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

709

3302

1.46

18.89

4.0

3.9

—

Use of biperiden

106

411

2.66

18.84

3.9

3.8

—

Colorectal cancer

393

2320

1.65

18.83

3.6

3.9

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

146

656

2.30

18.80

4.2

4.1

—

Other or ill-defined heart diseases

337

2.83

18.75

5.0

3.0

—

Disturbance of activity and attention

188

904

2.06

18.75

3.2

3.5

—

Caries of enamel

880

7894

0.72

18.70

3.7

—

Polyarteritis nodosa and related conditions

4.92

18.53

3.9

3.7

—

Hyperosmolality and hypernatraemia

4.91

18.52

6.4

3.2

—

Eating disorders

159

740

2.18

18.47

3.7

3.2

—

Open wound of forearm

182

896

2.07

18.42

4.3

3.6

—

Infection due to other mycobacteria, including avohilmo

112

4.43

18.39

6.0

3.6

—

Asthma and allergy, excluding more controls

131

556

2.35

18.34

2.7

2.4

—

Discitis, unspecified

130

4.16

18.30

5.7

4.0

—

Corticotropin deficiency

6.35

18.28

4.9

2.6

—

Aortic valve malfunction, age under 60 years

164

779

2.15

18.28

6.4

4.3

—

Vitamin D deficiency

121

4.25

18.27

3.7

3.3

—

Calculus of kidney and ureter

518

3428

1.53

18.25

4.0

3.9

—

Injury of nerves and spinal cord at neck level

167

3.72

18.21

3.5

3.9

—

Behavioural syndromes associated with physiological disturbances and physical factors

1439

7555

1.29

18.20

3.2

3.8

—

Crohn's disease of large intestine

355

2.75

18.14

3.8

3.5

—

Disorders of sclera, cornea, iris and ciliary body

849

6161

1.39

18.12

4.3

3.7

—

Disorders of psychological development

191

888

2.03

18.05

3.8

3.7

—

Abnormal weight loss

185

926

2.05

17.96

4.0

4.1

—

Other symptoms and signs involving the urinary system

193

980

2.01

17.94

4.5

4.1

—

Benign neoplasm of other and unspecified endocrine glands

227

1217

1.90

17.93

3.8

4.0

—

Seropositive rheumatoid arthritis

368

2246

1.65

17.92

4.7

3.6

—

Respiratory disorders in diseases classified elsewhere

102

4.62

17.92

6.7

3.5

—

Dermatitis due to substances taken internally

108

434

2.56

17.83

5.0

3.6

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

377

2334

1.64

17.82

4.1

3.7

—

Disorders of purine and pyrimidine metabolism

8.58

17.78

6.8

2.5

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

180

3.58

17.73

6.0

3.8

—

Deforming dorsopathies

428

2730

1.58

17.73

3.7

—

Pneumococcal septicemia

283

2.98

17.68

6.7

4.0

—

185

3.52

17.67

8.8

4.1

—

Arthrosis

1065

4339

1.35

17.65

3.6

3.4

—

Other diseases of arteries and capillaries

163

783

2.13

17.65

6.3

3.7

—

Mental and behavioural disorders due to tobacco

154

724

2.17

17.64

5.6

4.0

—

Drug-induced osteoporosis

4.82

17.61

3.8

2.9

—

Other follicular disorders

133

590

2.30

17.56

5.6

3.3

—

Traumatic subarachnoid haemorrhage

257

3.05

17.48

3.4

4.0

—

Smoking dependency

154

727

2.17

17.46

5.6

4.0

—

Acute drug-induced interstitial lung disorder

6.46

17.36

4.0

3.0

—

Spinal stenosis

830

4423

1.39

17.36

3.7

3.8

—

IBD patients in KELA-register

336

2033

1.67

17.35

3.2

3.7

—

Testicular dysfunction

319

2.82

17.31

4.0

3.8

—

Transport accidents

650

3760

1.45

17.27

3.5

—

Hyperkinetic disorders

197

992

1.96

17.24

3.2

3.6

—

Other diseases of spinal cord

239

3.14

17.20

6.3

4.0

—

Sicca syndrome [Sjögren]

141

647

2.23

17.17

3.3

3.6

—

Mixed hyperlipidaemia

299

2.87

17.07

5.3

3.5

—

Excessive vomiting in pregnancy

111

460

2.46

17.06

3.4

2.8

—

Dermatographic urticaria

115

486

2.42

16.99

3.9

3.2

—

Viral hepatitis, including avohilmo

131

586

2.29

16.98

4.3

3.4

—

Basal cell carcinoma

656

3108

1.45

16.98

3.7

3.9

—

Maternal care for other conditions predominantly related to pregnancy

240

1294

1.83

16.94

2.5

2.7

—

Explicit fungal Sepsis

7.28

16.90

10.9

2.0

—

Explicit fungal Sepsis, including avohilmo

7.27

16.90

10.9

2.0

—

Superficial injury of head

388

2446

1.60

16.90

3.7

3.8

—

Colitis, primary sclerosing, strict definition

6.14

16.89

2.9

3.0

—

Speech disturbances, not elsewhere classified

178

899

2.03

16.88

4.1

3.9

—

Viral hepatitis

125

551

2.32

16.79

4.5

3.4

—

Suppurative and unspecified otitis media

503

2968

1.51

16.78

4.4

3.5

—

Other (seronegative) rheumatoid arthritis, wide

303

1804

1.70

16.73

3.9

3.7

—

Acute posthaemorrhagic anaemia

264

2.98

16.73

6.7

3.5

—

Outcome of delivery

743

0.21

16.71

1.7

2.8

—

Toxic effects of substances chiefly nonmedicinal as to source

193

1005

1.96

16.68

3.6

4.0

—

6.46

16.61

4.9

2.1

—

Acute suppurative otitis media

357

2061

1.63

16.58

4.5

3.4

—

Disorders of eyelid, lacrimal system and orbit

1367

7834

1.28

16.54

3.4

3.8

—

Speech and linguistic disorders, excluding more controls

108

418

2.46

16.52

4.0

3.7

—

Testicular hypofunction

277

2.92

16.50

4.2

3.9

—

Immunodeficiency with predominantly antibody defects

178

3.46

16.49

7.5

3.2

—

Mental retardation

302

2.82

16.46

4.9

4.4

—

Focal brain injury

107

444

2.46

16.44

3.7

3.9

—

Non-follicular lymphoma

185

957

1.98

16.41

4.0

4.2

—

Glaucoma suspect

581

4018

1.46

16.40

4.0

3.8

—

Transient ischemic attack

841

4911

1.37

16.40

3.8

3.9

—

Chronic periodontitis, complicated

884

6393

1.36

16.37

4.4

3.8

—

Impotence

122

540

2.33

16.34

5.4

4.2

—

Special screening examination for infectious and parasitic diseases

1581

0.41

16.33

4.2

3.1

—

Colectomy operation

292

1735

1.71

16.30

4.1

3.9

—

Adult respiratory distress syndrome

4.52

16.29

8.6

3.3

—

Astigmatism

118

514

2.35

16.27

6.3

4.1

—

Other disorders of nervous system

130

592

2.25

16.22

4.0

4.3

—

Unknown and unspecified causes of morbidity

101

412

2.50

16.10

5.4

3.2

—

Parkinson's disease, excluding more controls

203

995

1.90

16.09

3.4

3.9

—

Osteonecrosis

120

532

2.32

15.98

6.0

3.9

—

Seronegative rheumatoid arthritis

183

950

1.96

15.97

3.5

—

Asthma mixed form (mode), excluding more controls

211

3.14

15.95

2.4

—

Monoamine oxidase A inhibitors

177

909

1.98

15.93

4.6

3.8

—

Other abnormal findings of blood chemistry

398

2.54

15.91

4.2

3.9

—

severe traumatic brain injury, does not include concussion

400

2582

1.57

15.90

4.0

3.9

—

Colitis, primary sclerosing

4.87

15.86

4.1

2.9

—

Asthma and allergy

131

594

2.20

15.74

2.7

2.5

—

Basal cell carcinoma, including Hilmo

670

3211

1.42

15.70

3.9

—

Mucosal proctocolitis

196

1048

1.90

15.63

3.3

3.7

—

Urticaria

414

2701

1.55

15.59

4.0

3.6

—

Rheumatoid arthritis, including avohilmo

567

3945

1.45

15.55

4.0

3.7

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

122

552

2.26

15.46

3.7

4.0

—

Diseases of middle ear and mastoid

828

4994

1.36

15.42

4.1

3.5

—

Blood alcohol or alcohol intoxication level

181

3.34

15.40

3.3

3.1

—

Other problems related to primary support group, including family circumstances

159

773

2.03

15.37

6.8

3.5

—

Abnormal involuntary movements

219

1220

1.82

15.35

3.8

4.0

—

Right bundle-branch block

249

2.94

15.35

4.5

3.2

—

Disorders of oesophagus in diseases classified elsewhere

167

3.45

15.30

5.9

4.3

—

Other and unspecified glaucoma

142

687

2.12

15.23

3.6

3.9

—

Congenital malformations of cardiac septa

111

469

2.34

15.22

4.7

4.6

—

Polycystic ovarian syndrome, consortium definition

903

3850

1.35

15.22

3.5

3.2

—

Polyuria

366

2340

1.58

15.20

3.6

3.8

—

Spondyloarthritis

274

1630

1.70

15.18

4.2

3.7

—

In situ neoplasms

631

4502

1.41

15.06

4.5

3.6

—

Mental retardation, wide definition

323

2.66

15.00

4.9

4.6

—

Inflammatory bowel disease, strict (require KELA)

336

2114

1.61

14.91

3.2

3.7

—

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

115

516

2.28

14.88

2.9

4.1

—

Atypical mycobacterium lung infection

4.63

14.79

6.6

2.8

—

Psoriatic and enteropathic arthropathies

174

913

1.94

14.73

3.3

3.4

—

Kyphosis

4.31

14.71

4.7

4.0

—

Injuries to the elbow and forearm

1070

7086

1.30

14.64

4.1

3.7

—

Inflammatory diseases of female pelvic organs

786

3957

1.37

14.63

3.6

3.2

—

Disorders of skin appendages

714

5194

1.38

14.62

4.3

3.6

—

Colorectal adenocarcinoma

327

2028

1.61

14.61

3.7

3.9

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

101

434

2.39

14.50

3.9

4.0

—

Sequelae of cerebrovascular disease

619

3773

1.41

14.49

4.0

3.9

—

Pain in joint

797

3607

1.36

14.44

3.9

3.7

—

Other obstetric conditions, not elsewhere classified

343

1354

1.61

14.34

2.4

—

Diseases of male genital organs

841

3136

1.36

14.29

4.2

4.1

—

Squamous cell neoplasms and carcinomas of the skin

189

1032

1.86

14.20

4.7

3.8

—

Complications following infusion, transfusion and therapeutic injection

103

4.10

14.20

4.8

2.5

—

Mixed specific developmental disorders

123

3.67

14.18

5.2

6.2

—

Carcinoma in situ of skin, other sites/unspecified

136

3.67

14.18

5.7

4.0

—

Other abnormal findings in urine

131

3.71

14.18

5.6

4.0

—

Personal history of risk-factors, not elsewhere classified

4.85

14.16

4.3

2.7

—

Thyrotoxicosis, other and/or unspecified

283

1730

1.65

14.16

3.3

3.5

—

Septal defects

105

453

2.32

14.15

4.5

4.3

—

Redundant prepuce, phimosis and paraphimosis

341

2147

1.58

14.10

3.8

4.0

—

Primary biliary cholangitis, wide definition

126

3.70

14.10

5.5

3.3

—

Diastasis of muscle

5.87

14.03

2.5

3.1

—

Myocardial infarction, unclassifiable

406

2409

1.52

14.00

5.1

3.9

—

Biological medication for rheuma

249

1477

1.71

14.00

2.9

3.8

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

335

1321

1.61

13.97

2.5

2.4

—

Heart failure and hypertrophic cardiomyopathy

157

3.43

13.96

6.7

3.6

—

Abnormal blood-pressure reading, without diagnosis

262

2.77

13.95

2.9

3.4

—

Acute laryngitis and tracheitis

159

812

1.95

13.87

4.2

3.2

—

Rash and other nonspecific skin eruption

163

856

1.94

13.85

4.7

4.0

—

Other ulcerative colitis

100

437

2.34

13.81

4.6

3.7

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

794

5740

1.34

13.78

3.7

3.9

—

Generalized skin eruption due to drugs and medicaments

282

2.70

13.74

4.7

3.8

—

ILD and respiratory illness in diseases classified elsewhere

6.72

13.73

8.4

2.5

—

Papilloedema, unspecified

148

3.44

13.72

4.4

3.1

—

Other disorders of lacrimal gland

541

3822

1.43

13.71

3.6

3.7

—

Symptoms and signs involving speech and voice

502

3501

1.45

13.69

3.7

—

Malignant neoplasm of brain, including Hilmo

347

2.51

13.66

3.2

3.8

—

Sleep disorders

1336

7344

1.26

13.62

3.1

3.8

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

225

1296

1.75

13.60

4.7

3.8

—

ILD medications: pirfenidone

4.43

13.53

7.1

2.7

—

Status post-ami

396

1988

1.53

13.51

4.1

3.5

—

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

115

537

2.19

13.51

3.6

3.9

—

Other disorders of veins

584

4122

1.40

13.51

4.4

3.5

—

Cerebral palsy and other paralytic syndromes

181

992

1.85

13.46

5.2

3.9

—

Myalgia

330

2119

1.57

13.45

3.2

3.6

—

Diseases of spleen

131

3.60

13.39

5.4

3.7

—

Disorders of muscles

164

873

1.91

13.36

3.9

3.8

—

Malignant neoplasm of mesothelium and soft tissue

292

2.64

13.35

2.6

4.0

—

Otitis media, unspecified

169

833

1.89

13.32

6.2

3.3

—

Superficial injuries involving multiple body regions

187

3.10

13.29

3.1

3.0

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

241

2.81

13.29

5.0

3.0

—

Cushing syndrome

4.76

13.28

4.3

1.8

—

Previous suicide attempt

5.02

13.26

4.2

2.8

—

Cardiomyopathy, Hypertrophic obstructive

4.00

13.22

7.8

3.4

—

malignant neoplasm of female genital organs, including Hilmo

226

1263

1.72

13.17

3.4

3.5

—

Abnormal findings on diagnostic imaging of central nervous system

360

2.45

13.11

3.9

3.8

—

Disorders of lacrimal system

650

4691

1.37

13.11

3.4

3.7

—

Hypertension, Pulmonary Arterial

6.47

13.10

5.5

2.6

—

Injuries to the neck

340

2216

1.55

13.01

3.6

3.8

—

Injuries involving multiple body regions

296

2.61

13.00

3.0

3.6

—

Brachial plexus disorders

130

646

2.04

12.94

2.9

3.4

—

Other diseases of stomach and duodenum

118

567

2.13

12.94

6.0

4.1

—

6.63

12.93

8.5

2.5

—

Hodgkin lymphoma, hilmo

201

2.99

12.92

5.5

3.7

—

Type1 diabetes, definitions combined, early onset

100

448

2.27

12.88

4.1

3.9

—

Scabies

376

2.40

12.85

6.2

3.5

—

Malignant neoplasm of heart, mediastinum and pleura

4.19

12.84

2.7

3.1

—

Appendectomy

902

6617

1.30

12.84

3.7

3.6

—

Budesonide

195

1109

1.78

12.80

3.8

3.2

—

Amenorrhoea

394

2.35

12.79

3.7

2.9

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

157

614

1.94

12.78

3.4

3.9

—

Mild mental retardation

181

3.09

12.77

4.7

3.9

—

Other/unspecified mastoiditis and related conditions

6.82

12.76

2.5

2.7

—

Other specified/unspecified soft tissue disorders

365

2.41

12.73

3.8

3.7

—

Familial hypercholesterolemia

232

1388

1.69

12.72

3.6

3.7

—

Functional dyspepsia

384

2584

1.50

12.63

3.8

3.6

—

Congenital malformations of the circulatory system

215

1225

1.73

12.61

5.1

4.1

—

Lichen simplex chronicus and prurigo

112

533

2.15

12.60

6.1

3.6

—

Malignant neoplasm of rectum, including Hilmo

193

1101

1.78

12.59

3.7

3.9

—

malignant neoplasm of male genital organs, including Hilmo

478

1987

1.46

12.59

3.8

4.2

—

Pediculosis, acariasis and other infestations

106

494

2.19

12.58

5.8

3.8

—

Migraine without aura and triptan purchases

203

1173

1.75

12.58

3.3

3.2

—

Other symptoms and signs involving cognitive functions and awareness

761

5092

1.33

12.57

3.8

3.9

—

Personal history of other diseases and conditions

136

690

1.99

12.55

3.8

2.7

—

Migraine with aura and triptan purchases

197

1131

1.76

12.50

2.7

3.3

—

Other and unspecified injuries of lower leg

123

609

2.06

12.41

3.6

3.8

—

Drug-induced cataract

179

3.08

12.41

8.2

3.2

—

Injuries to unspecified part of trunk, limb or body region

172

953

1.84

12.41

4.7

3.9

—

Other misadventures during surgical and medical care

190

3.01

12.37

4.7

3.4

—

Otitis externa, unspecified

178

997

1.81

12.36

5.0

4.0

—

Recurrent and persistent haematuria

4.92

12.36

4.8

1.9

—

Schizotypal disorder

153

3.25

12.35

2.1

3.1

—

Paracetamol or NSAID medication

236

695

1.73

12.32

3.6

4.2

—

Other immunodeficiencies

4.84

12.30

4.5

2.5

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

505

3547

1.41

12.27

3.5

3.6

—

Crohn's disease of small intestine

106

499

2.16

12.24

3.1

3.6

—

Urethral stricture

111

534

2.13

12.18

4.3

4.4

—

Wegener granulomatosis

115

3.66

12.18

5.4

3.4

—

Asthma mixed form (mode)

246

2.69

12.17

2.4

2.7

—

Disorders of adrenal gland, other and/or unspecified

10.68

12.12

2.8

2.0

—

Acute bronchiolitis

369

2.29

11.99

7.1

3.8

—

Hyperhidrosis

150

3.20

11.99

3.0

2.8

—

Disorders of parathyroid gland, other and/or unspecified

5.15

11.94

7.9

2.5

—

Hypermetropia

119

591

2.05

11.91

5.9

4.1

—

Mixed disorders of conduct and emotions

136

3.33

11.88

4.6

3.6

—

Ulcerative rectosigmoiditis

125

634

2.01

11.82

3.5

3.8

—

Other inflammatory liver diseases

111

540

2.10

11.81

5.7

3.9

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

127

3.45

11.80

5.1

3.3

—

Anorexia (incl.atypical)

396

2.29

11.79

4.1

3.5

—

Dissocial personality disorder

103

3.75

11.78

4.4

3.4

—

Benign paroxysmal vertigo

447

3144

1.44

11.74

3.8

3.7

—

Iridocyclitis

332

2206

1.52

11.69

4.1

3.8

—

Biological medicines for asthma

148

3.22

11.68

3.5

2.9

—

Other factor of the environment

4.15

11.65

3.9

2.6

—

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

3.77

11.63

2.2

2.9

—

Presence of other devices

132

2400

0.54

11.61

2.6

3.6

—

Prurigo nodularis

186

2.96

11.60

6.9

3.3

—

Habit and impulse disorders

3.92

11.60

2.0

2.2

—

Scoliosis

128

659

1.97

11.59

4.6

3.7

—

Acute and subacute iridocyclitis

282

1814

1.57

11.54

4.1

3.9

—

Disorders of optic nerve and visual pathways

143

766

1.90

11.52

4.4

3.6

—

Acute generalized exanthematous pustulosis

339

2.39

11.48

4.6

3.7

—

Sequelae of injuries, of poisoning and of other consequences of external causes

337

2258

1.51

11.40

3.6

3.8

—

Neovascular glaucoma

353

2.36

11.39

6.0

4.0

—

Malignant neoplasm of endocrine gland, including Hilmo

115

574

2.04

11.39

4.7

3.9

—

malignant neoplasm of male genital organs

463

1957

1.44

11.37

3.8

4.3

—

Hidradenitis suppurativa

244

2.65

11.37

6.2

3.0

—

Assault by unspecified means

135

3.30

11.37

4.1

3.5

—

Primary open-angle glaucoma, strict

433

3040

1.44

11.36

4.0

3.9

—

Viral infections of the central nervous system

110

541

2.07

11.36

4.4

3.7

—

Disorders of phosphorus metabolism and phosphatases

10.21

11.36

4.9

2.3

—

Asthma and opportunity respiratory infection

385

2.29

11.35

5.4

4.1

—

Disorder of lipoprotein metabolism, unspecified

197

1165

1.71

11.35

5.0

3.7

—

Herpesviral [herpes simplex] infections

174

994

1.78

11.34

5.5

3.5

—

Pulmonary oedema

151

3.18

11.34

7.0

4.0

—

Carcinoma in situ of skin of other and unspecified parts of face

166

938

1.81

11.33

5.0

4.0

—

Other symptoms and signs involving general sensations and perceptions

360

2.34

11.33

5.3

3.9

—

Irregular menses

553

3023

1.38

11.33

3.4

3.1

—

malignant neoplasm of female genital organs

198

1146

1.71

11.30

3.3

3.6

—

Acute nephritic syndrome

146

3.20

11.30

7.2

3.3

—

Other and unspecified diseases of blood and blood-forming organs

189

2.90

11.27

5.7

3.4

—

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

126

3.38

11.24

2.8

3.9

—

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

412

2.24

11.24

3.7

4.0

—

Heterophoria

122

625

1.98

11.23

3.9

3.6

—

Amputation of foot

247

2.65

11.21

8.9

3.9

—

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

152

3.14

11.20

3.2

4.1

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

212

2.78

11.20

4.9

3.9

—

Multiple myeloma

212

2.78

11.20

4.9

3.9

—

Secondary parkinsonism, excluding more controls

157

3.08

11.18

4.6

4.0

—

Coxarthrosis [arthrosis of hip](FG)

794

4198

1.31

11.16

3.8

3.6

—

Cluster headache, wide

206

2.78

11.15

4.5

3.3

—

Visual field defects

146

797

1.87

11.14

4.2

4.0

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

365

2498

1.48

11.13

4.7

3.7

—

Other disorders of electrolyte and fluid balance, not elsewhere classified

5.07

11.12

4.3

2.6

—

Event of undetermined intent

107

526

2.07

11.09

4.2

3.5

—

Mesothelioma, including Hilmo

3.90

11.04

3.0

4.4

—

Sciatica+with lumbago

731

4954

1.31

10.97

3.2

3.7

—

Visual disturbances

719

5507

1.31

10.96

3.9

3.7

—

Congenital malformations of heart and great arteries

189

1082

1.72

10.93

4.6

4.2

—

Other arterial embolism and thrombosis

238

2.65

10.93

6.2

3.8

—

Patent foramen ovale

165

3.02

10.93

5.3

4.8

—

Malignant neoplasm of brain

232

2.65

10.89

2.4

4.0

—

Late syphilis, including avohilmo

129

3.33

10.87

9.2

3.4

—

Social phobias

109

542

2.04

10.87

2.1

3.0

—

Abscess of anal and rectal regions

131

696

1.91

10.84

4.1

3.9

—

Tumor necrosis factor alpha inhibitors

215

1318

1.65

10.79

2.9

3.6

—

Use of trihexyphenidyl

29.22

10.78

7.2

2.5

—

Myocardial infarction, with ST-elevation

302

2005

1.53

10.77

5.4

3.9

—

Syphilis, including avohilmo

194

2.83

10.75

7.9

3.7

—

Syphilis

194

2.83

10.75

7.9

3.7

—

Pure hyperglyceridaemia

145

3.14

10.75

3.6

—

Abnormality of white blood cells, not elsewhere classified

4.61

10.71

6.9

2.9

—

Adhesive capsulitis of shoulder

238

1499

1.61

10.71

3.6

3.9

—

Tracheo-bronchomalasia

15.37

10.70

2.9

3.9

—

Glaucoma secondary to other eye disorders

363

2.29

10.69

6.0

4.1

—

Manic episode

200

2.77

10.67

5.5

3.6

—

Chronic sinusitis

600

4493

1.34

10.63

3.9

3.7

—

Late syphilis

106

3.58

10.62

10.3

3.3

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

355

2.27

10.61

5.0

3.9

—

Impetigo

326

2.35

10.58

4.3

3.3

—

Malignant neoplasm of colon, including Hilmo

278

1811

1.55

10.58

3.4

3.8

—

Keratitis

513

3764

1.37

10.52

4.6

3.7

—

Malignant neoplasm of small intestine

147

3.10

10.52

5.5

4.1

—

Malignant neoplasm of prostate, including Hilmo

458

1921

1.42

10.51

3.7

4.3

—

Other special examinations and investigations of persons without complaint or reported diagnosis

1045

4216

1.26

10.49

4.0

3.6

—

Other coagulation defects

118

613

1.96

10.49

5.9

3.7

—

Psoriatic arthropathies

144

797

1.83

10.48

3.4

—

Polyglandular dysfunction

17.35

10.47

9.4

1.5

—

Other/unspecified rheumatoid arthritis

191

1147

1.69

10.45

4.6

3.7

—

Benign neoplasm: Adrenal gland

131

706

1.89

10.45

3.7

4.1

—

Autoimmune hepatitis, wide definition

297

2.41

10.44

5.7

3.4

—

Disorders of myoneural junction and muscle in diseases classified elsewhere

5.01

10.43

4.7

1.8

—

Nonsuppurative otitis media

312

1811

1.51

10.43

5.0

3.5

—

Dislocation, sprain and strain of joints and ligaments of head

255

2.52

10.40

4.7

3.9

—

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

9.34

10.38

7.5

2.3

—

Open wound of wrist and hand

655

4819

1.32

10.38

3.5

3.9

—

Malignant neoplasm of endocrine gland

485

2.08

10.36

4.8

3.9

—

Psoriasis

405

2865

1.43

10.36

4.3

3.8

—

Extrapyramidal and movement disorders

596

4486

1.34

10.36

3.5

3.8

—

Other specific joint derangements/joint disorders

998

4957

1.26

10.31

3.8

3.4

—

438

2.13

10.30

3.9

3.5

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

218

1359

1.62

10.28

5.7

3.8

—

Anterior Iridocyclitis

294

1960

1.52

10.27

4.0

3.8

—

Visual disturbances and blindness

774

6033

1.29

10.27

3.9

3.7

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

408

2.18

10.26

3.4

3.9

—

Autism

165

2.92

10.25

2.4

3.7

—

Metabolic disorder, other/unspecified

14.03

10.25

3.0

3.1

—

Ovarian cyst

433

1747

1.43

10.25

3.5

3.2

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

113

3.38

10.24

8.6

2.9

—

Heartburn

152

861

1.79

10.23

3.4

3.9

—

Diabetes mellitus in pregnancy

322

1369

1.50

10.19

3.0

2.6

—

Diseases of oral cavity, salivary glands and jaws

897

3630

1.28

10.18

3.9

3.6

—

Orchitis and epididymitis

162

939

1.75

10.13

4.1

4.4

—

Lesion of ulnar nerve

207

1279

1.64

10.13

4.1

3.9

—

Oesophagitis

457

2.10

10.10

5.9

3.9

—

Malignant neoplasm of colon

232

1474

1.59

10.10

3.5

3.9

—

Paralytic ileus

321

2.33

10.10

4.9

3.9

—

Diabetic neuropathy

260

1693

1.56

10.10

6.5

4.1

—

Insomnia

1274

7284

1.22

10.08

3.0

3.7

—

Primary open-angle glaucoma

510

3621

1.37

10.08

3.8

3.9

—

Other/unspecified seropositive rheumatoid arthritis

366

2557

1.44

10.06

4.7

3.7

—

Parkinson's disease, strict definition, excluding more controls

174

958

1.71

10.02

3.2

3.9

—

Thyrotropin deficiency

4.09

10.02

4.1

2.6

—

Viral warts, including avohilmo

299

2011

1.50

9.99

5.1

3.6

—

Assault by bodily force

115

602

1.94

9.99

3.6

3.2

—

Other and unspecified spinal muscular atrophies

4.64

9.98

4.6

4.1

—

Unspecified misadventure during surgical and medical care

100

500

2.04

9.98

4.4

3.9

—

Pilonidal cyst

117

617

1.92

9.93

3.3

—

Autoimmune polyglandular failure

28.12

9.93

8.9

1.3

—

Symptoms and signs involving emotional state

214

2.64

9.90

3.9

—

Other and unspecified local infections of skin and subcutaneous tissue

152

871

1.77

9.89

6.6

3.8

—

Other noninfective disorders of lymphatic vessels and lymph nodes

262

2.47

9.87

5.2

3.8

—

Evidence of alcohol involvement determined by level of intoxication

4.26

9.84

3.7

3.2

—

Pre-eclampsia

212

1326

1.61

9.82

4.0

2.9

—

Hypoplasia of dental enamel , including avohilmo

211

2.61

9.82

13.4

3.4

—

Other shoulder lesions

137

763

1.82

9.80

3.9

—

Acute lymphadenitis

402

2.15

9.80

5.1

3.6

—

Ulcerative colitis (strict definition, require KELA)

231

1477

1.58

9.79

3.3

3.8

—

Microscopic polyangiitis

4.99

9.77

8.5

3.0

—

Seropositive rheumatoid arthritis, wide

368

2588

1.43

9.77

4.7

3.7

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

224

1423

1.59

9.76

3.4

3.8

—

Wide developmental disorders

226

2.57

9.76

2.7

4.6

—

Lifestyle-related condition

3.90

9.76

4.1

2.7

—

Varicose veins

884

5304

1.26

9.75

4.3

3.6

—

Hyperplasia of prostate

599

2533

1.34

9.73

4.2

—

Malignant neoplasm of liver and intrahepatic bile ducts

258

2.47

9.73

4.1

4.2

—

Membranous nephropathy

9.04

9.71

8.3

2.7

—

Trigger finger

198

1223

1.64

9.70

3.6

3.8

—

Other abnormal uterine and vaginal bleeding

298

1433

1.51

9.70

3.5

3.3

—

Pyoderma gangrenosum

4.86

9.69

6.5

2.4

—

Adalimumab

137

766

1.81

9.68

2.9

3.7

—

Pediculosis, acariasis and other infestations, including avohilmo

236

1520

1.57

9.67

4.6

3.7

—

102

3.42

9.65

4.2

2.1

—

Sequelae of infectious and parasitic diseases

114

603

1.92

9.64

4.7

3.7

—

Thyrotoxicosis

340

2363

1.45

9.63

3.2

3.6

—

Cyst of kidney

126

690

1.86

9.61

5.7

3.9

—

Pre-eclampsia or poor fetal growth

316

2155

1.47

9.60

3.9

2.8

—

Malignant neoplasm of other and unspecified parts of biliary tract

108

3.38

9.59

3.7

3.5

—

Other fall from one level to another

329

2274

1.46

9.58

3.5

4.0

—

Adenocarcinoma and papilloma adenocarcinoma of rectum

150

865

1.76

9.56

3.7

4.0

—

Pleural plaque without asbestos

375

2.20

9.56

4.2

4.0

—

Thrombotic microangiopathy

5.51

9.53

5.4

3.0

—

Periodontitis

1473

7857

1.20

9.53

3.9

3.7

—

Thyroiditis, ILD-related definition

151

873

1.75

9.51

3.5

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

155

904

1.74

9.49

3.7

4.0

—

Other local infections of skin and subcutaneous tissue

159

934

1.73

9.49

6.5

3.8

—

Malignant neoplasm of prostate

442

1884

1.40

9.46

3.8

4.3

—

Familial hypercholesterolemia, with ischemic heart disease

146

840

1.77

9.42

4.1

3.9

—

Autism spe

162

2.85

9.41

2.0

3.4

—

Sequelae of infectious and parasitic diseases, including avohilmo

115

616

1.90

9.37

4.8

3.7

—

Coxarthrosis

731

3671

1.29

9.35

3.9

3.6

—

Mesothelioma

3.90

9.34

2.9

3.7

—

Amiodarone users

172

1038

1.69

9.34

4.1

4.2

—

Benign neoplasm: Pancreas

221

2.57

9.34

4.9

3.9

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

243

1589

1.54

9.34

3.3

3.7

—

Other congenital malformations

117

630

1.88

9.33

5.0

3.9

—

Injury of other and unspecified intrathoracic organs

113

604

1.91

9.31

4.3

4.1

—

Hydrocephalus in other diseases

5.38

9.28

5.9

2.7

—

Injury of unspecified body region

125

690

1.84

9.27

4.8

4.0

—

Certain conditions originating in the perinatal period

110

513

1.93

9.27

6.9

3.4

—

Faecal incontinence

128

711

1.83

9.27

4.1

3.6

—

Assault by other specified means

4.45

9.24

4.0

3.1

—

Allergic bronchopulmonary aspergillosis (ABPA)

16.92

9.22

5.2

3.1

—

Other and unspecified immunodeficiencies with predominantly antibody defects

3.92

9.19

8.6

2.4

—

IBD (strict) with PSC

4.77

9.17

5.8

3.4

—

Disorders of vestibular function (Vertigo)

684

5194

1.29

9.17

3.4

3.7

—

Intercostal neuropathy

4.33

9.17

5.5

3.0

—

Viral infections of the central nervous system, including avohilmo

113

607

1.89

9.13

4.3

3.7

—

Nonhereditary hypogammaglobulinemia

4.26

9.11

6.5

3.0

—

Obsessive-compulsive disorder

420

2.07

9.10

2.8

3.1

—

Magnesium deficiency

12.05

9.10

3.7

2.1

—

Injuries to the wrist and hand

1501

8384

1.19

9.09

3.5

3.7

—

Chronic periodontitis, including avohilmo

1466

7861

1.19

9.09

3.9

3.7

—

Hypermobility syndrome

316

2.25

9.08

2.7

2.8

—

Congenital malformations of the musculoskeletal system, not elsewhere classified

3.66

9.05

1.9

3.0

—

Sleep disorders, other/unspecified

236

2.47

9.03

4.4

3.4

—

Mycoses, including avohilmo

1359

8661

1.20

9.03

4.2

3.6

—

Striae atrophicae

4.35

9.02

2.9

2.1

—

Malignant neoplasm of small intestine, including Hilmo

219

2.53

8.98

5.0

4.0

—

Primary hyperparathyroidism

162

972

1.69

8.98

4.7

3.7

—

Follow-up examination after treatment for conditions other than malignant neoplasms

387

3559

0.72

8.97

3.4

3.7

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

371

2.16

8.97

3.7

4.4

—

Cluster headache, strict

195

2.61

8.96

4.8

3.3

—

Viral encephalitis, not elsewhere classified/unspecified

156

2.86

8.95

4.7

3.8

—

Malignant neoplasm, without specification of site, including Hilmo

397

2.11

8.94

3.2

3.9

—

Malignant neoplasm of rectum

149

875

1.73

8.93

3.6

4.0

—

Hypothermia

162

2.83

8.93

5.0

4.0

—

Drug- and heavy-metal-induced tubulo-interstitial and tubular conditions

10.34

8.92

12.2

2.1

—

Inflammatory diseases of the central nervous system

126

706

1.81

8.91

5.8

3.9

—

Fracture of skull and facial bones

295

2033

1.46

8.79

3.5

3.9

—

Other and unspecified follicular disorders

341

2.19

8.77

4.8

3.4

—

Striking against or struck by other objects

469

3492

1.35

8.75

3.8

3.9

—

Defects in the complement system

5.04

8.73

3.3

2.6

—

Seborrhoeic dermatitis

154

919

1.70

8.72

6.2

3.8

—

104

3.26

8.71

3.9

3.4

—

Other disorders of optic [2nd] nerve and visual pathways

101

532

1.93

8.71

4.8

3.7

—

Cardiac murmurs and other cardiac sounds

117

637

1.84

8.70

3.8

3.7

—

Neuralgia and neuritis, unspecified

382

2.11

8.66

3.3

3.8

—

Evidence of alcohol involvement determined by blood alcohol level

110

3.22

8.66

2.9

3.2

—

Sequelae of injuries of neck and trunk

223

2.49

8.65

3.7

3.6

—

Persistent delusional disorders

114

626

1.85

8.63

3.7

—

Haemolytic anaemias

273

2.33

8.61

5.9

4.0

—

Other and unspecified psoriasis

109

591

1.88

8.61

4.2

4.1

—

Use of riluzole

5.39

8.61

4.8

2.6

—

Paraplegia, diplegia of upper limbs

171

2.72

8.58

5.2

3.4

—

Anosmia

4.85

8.56

4.8

2.1

—

Coeliac disease

168

1031

1.65

8.53

4.5

3.7

—

Acquired haemolytic anaemia

189

2.62

8.53

5.8

3.8

—

Malignant neoplasm of eye, brain and central nervous system

306

2.23

8.50

2.3

3.8

—

Intracranial and intraspinal abscess and granuloma

3.54

8.50

3.2

2.8

—

Other and unspecified abdominal hernia

359

2.14

8.50

4.7

4.2

—

Arthropathic psoriasis

156

942

1.68

8.45

3.9

4.0

—

Preterm labour and delivery

271

1851

1.47

8.44

3.0

3.4

—

Adenocarcinoma and Papillary adenocarcinoma of kidney

3.68

8.39

5.6

3.5

—

Alzheimer disease, excluding more controls

240

1022

1.53

8.39

3.5

3.9

—

Pre-eclampsia or eclampsia

224

1475

1.53

8.36

4.0

3.1

—

Myeloid leukaemia

215

2.49

8.35

3.5

3.9

—

Other orthopaedic follow-up care

381

2.08

8.33

2.9

3.1

—

Degenerative macular diseases

193

1234

1.59

8.31

3.7

3.9

—

Hepatomegaly and splenomegaly, not elsewhere classified

4.39

8.30

7.2

3.1

—

Salpingitis and oophoritis

202

1304

1.56

8.28

4.7

3.2

—

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

163

2.73

8.26

4.7

3.8

—

Myositis

186

2.60

8.25

4.8

3.9

—

Ehlers-Danlos syndrome, including avohilmo

4.04

8.24

1.7

—

Soft tissue disorders related to use, overuse and pressure

383

2798

1.38

8.21

4.1

3.8

—

L04AC Interleukin inhibitors

480

1.95

8.17

3.2

3.7

—

Osteonecrosis due to drugs

109

3.16

8.15

3.6

3.9

—

Atopic dermatitis, strict definition with reimbursement

355

2461

1.39

8.13

4.6

3.3

—

Molar incisor enamel hypoplasia

236

2.35

8.12

13.4

3.4

—

Toxic effect of corrosive substances

7.10

8.10

3.5

4.8

—

Disorders of synovium and tendon

731

4939

1.26

8.10

3.8

3.7

—

Strabismus

349

2510

1.40

8.10

4.6

3.8

—

Anankastic personality disorder

236

2.38

8.09

1.6

2.8

—

Pain and other conditions associated with female genital organs and menstrual cycle

238

1330

1.51

8.06

2.1

3.0

—

Scabies, including avohilmo

193

1242

1.57

8.04

4.9

3.7

—

Hepatocellular carcinoma

183

2.59

8.02

4.7

4.0

—

Infections with a predominantly sexual mode of transmission, including avohilmo

465

3204

1.33

8.02

4.3

3.3

—

Mantle cell lymphoma

3.77

8.01

3.2

3.1

—

Vitamin B12 deficiency anaemia

160

987

1.64

8.01

3.9

3.7

—

Wet age-related macular degeneration

296

2005

1.44

8.00

3.8

—

Ulcerative colitis (strict) with PSC

4.84

7.98

3.8

3.7

—

Secondary malignant neoplasm of respiratory and digestive organs

121

2.99

7.97

1.7

3.5

—

Acute myeloid leukaemia and myelodysplastic syndromes

172

2.63

7.94

4.9

3.7

—

Sequelae of injuries of upper limb

141

844

1.69

7.94

3.5

3.9

—

Complications of genitourinary prosthetic devices, implants and grafts

172

2.63

7.93

3.7

3.6

—

Excessive earwax

953

7104

1.22

7.91

3.7

3.9

—

Eustachian salpingitis and obstruction

105

578

1.84

7.90

4.3

3.1

—

Other female pelvic inflammatory diseases

185

1185

1.58

7.88

2.8

3.2

—

Malignant neoplasm of head and neck, including Hilmo

139

831

1.69

7.85

4.3

4.1

—

Bronchitis, not specified as acute or chronic

112

630

1.80

7.85

3.1

3.4

—

Other disorders starting during childhood or adolescence

352

2.09

7.85

5.1

4.3

—

Conjunctivitis (acute, non atopic)

375

2739

1.37

7.84

4.5

3.8

—

Papulosquamous disorders

538

4161

1.30

7.81

4.3

3.8

—

Artificial joint operation, meniscal resection

1351

7317

1.18

7.78

3.5

3.9

—

Ehlers-Danlos syndrome

4.48

7.76

1.8

1.9

—

Rare circulating lymphoid malignancy, including Hilmo

210

2.44

7.76

4.7

4.5

—

Congenital iodine-deficiency syndrome/hypothyroidism

198

2.49

7.74

3.7

3.6

—

Seropositive rheumatoid arthritis, strict definition

204

1343

1.54

7.72

4.3

3.8

—

Malignant neoplasm of breast, including Hilmo

442

2114

1.35

7.70

3.3

—

Myopia

161

1004

1.62

7.69

4.7

3.4

—

Coxibs

463

1818

1.34

7.68

3.5

4.6

—

Other and unspecified coagulation defects

373

2.05

7.68

5.7

3.7

—

Myeloproliferative diseases

134

800

1.70

7.67

3.4

4.0

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

442

2116

1.34

7.66

3.3

—

Spondylopathies (FG)

172

1091

1.59

7.66

3.2

3.3

—

Appendicitis, broad definition

1020

7600

1.21

7.66

3.9

3.7

—

Pneumoconiosis due to asbestos and other mineral fibres

206

2.46

7.64

3.9

3.8

—

Achalasia of cardia

124

2.92

7.64

4.0

4.4

—

Non-small cell lung cancer, squamous

429

1.97

7.63

4.6

4.2

—

Melanocytic naevi, other sites/unspecified

119

688

1.75

7.62

6.8

3.7

—

Primary biliary cholangitis (PBC)

113

3.00

7.61

6.1

3.8

—

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

8.38

7.61

5.1

2.1

—

Acne

131

773

1.70

7.60

6.6

3.1

—

Hepatocellular carcinoma, including Hilmo

244

2.31

7.57

4.1

—

Underdevelopment of the second kidney

15.38

7.56

14.3

2.6

—

Olecranon bursitis

103

573

1.83

7.56

5.6

4.3

—

Acute gastritis

111

631

1.79

7.55

4.7

3.7

—

Cramp and spasm

369

2.04

7.54

3.6

3.5

—

Ulcer of oesophagus

110

625

1.79

7.52

5.7

4.1

—

Malignant neoplasm of breast

434

2093

1.34

7.50

3.4

3.3

—

Diseases of appendix

1027

7646

1.20

7.49

3.8

3.7

—

Other specified congenital malformation syndromes affecting multiple systems

3.21

7.48

6.9

4.8

—

Ovarian dysfunction

431

1.95

7.48

2.5

2.3

—

Other and unspecified injuries of ankle and foot

303

2.15

7.47

4.7

3.6

—

Chronic myeloid leukaemia, including Hilmo

4.18

7.45

2.2

2.6

—

Chronic myeloproliferative disease

3.16

7.44

2.6

2.9

—

Unspecified/other endometriosis

104

569

1.81

7.44

2.6

2.7

—

Malignant neoplasm of breast, HER2-negative

433

2093

1.34

7.39

3.4

3.3

—

Volvulus

215

2.38

7.39

5.0

3.9

—

Superficial injury of wrist and hand

271

1904

1.43

7.36

3.7

4.0

—

Urethritis and urethral syndrome

132

2.80

7.36

5.1

3.4

—

Nonsuppurative otitis media, including avohilmo

395

2544

1.35

7.35

4.5

3.4

—

Polycythaemia vera

241

2.29

7.32

3.8

4.0

—

Bacterial, viral and other infectious agents

117

682

1.74

7.30

5.1

3.9

—

Disorders of continuity of bone

131

787

1.68

7.30

5.1

3.5

—

Gingivitis and periodontal diseases

1477

6526

1.17

7.28

3.8

3.7

—

Other neurotic disorders

374

2.02

7.28

4.9

4.0

—

Osteomyelitis of vertebra

7.82

7.27

8.6

3.4

—

Memory loss

950

0.43

7.26

4.0

—

Carcinoma in situ of skin of trunk

328

2.10

7.25

4.0

4.1

—

Peptic ulcer

3.59

7.23

3.2

—

Anuria and oliguria

3.98

7.23

8.4

3.0

—

Malignant neoplasm of other connective and soft tissue, including Hilmo

301

2.13

7.21

2.9

3.9

—

Superficial injury of ankle and foot

162

1029

1.59

7.21

4.2

3.9

—

Disturbances of skin sensation

349

2569

1.37

7.20

2.8

3.7

—

Chronic hepatitis, not elsewhere classified

230

2.31

7.20

5.3

3.5

—

Malignant neoplasm of corpus uteri, including Hilmo

117

685

1.73

7.19

3.2

3.5

—

Hydrocele

195

1293

1.53

7.19

4.0

4.3

—

Excessive attrition of teeth

810

6562

1.23

7.18

4.0

3.6

—

Alzheimer’s disease, strict definition

247

2837

0.70

7.16

3.2

3.9

—

Sequelae of other and unspecified infectious and parasitic diseases

383

1.99

7.15

5.0

3.3

—

Infection of intervertebral disc (pyogenic)

107

3.02

7.13

3.9

4.4

—

Other bacterial agents as the cause of diseases classified to other chapters, including avohilmo

3.20

7.12

10.5

2.8

—

Bacterial, viral and other infectious agents, including avohilmo

123

732

1.70

7.12

5.2

3.9

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

409

3089

1.33

7.12

3.9

3.8

—

Other and unspecified mental retardation

106

2.99

7.08

4.6

5.4

—

Diabetes insipidus

4.02

7.08

3.8

2.4

—

Portal vein thrombosis

124

2.84

7.07

3.4

3.9

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

113

659

1.74

7.07

5.9

3.7

—

Impaction of intestines

4.58

7.06

3.6

3.5

—

Tobacco use

434

1.92

7.06

6.2

3.6

—

Other conditions related to polyarteritis nodosa

10.61

7.06

2.8

3.8

—

Assault by sharp object

124

2.83

7.06

7.3

3.7

—

Colon adenocarcinoma

179

1170

1.55

7.05

3.6

3.9

—

Osteopathy in diseases classified elsewhere

4.17

7.01

4.9

2.7

—

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

386

1.97

7.01

5.0

3.3

—

Other bursopathies

184

1212

1.53

6.99

5.3

3.9

—

Dislocation, sprain and strain of joints and ligaments at neck level

192

1277

1.52

6.95

3.2

3.6

—

Other disorders of eyelid

660

5007

1.25

6.94

3.3

3.9

—

Fall involving bed

313

2.10

6.94

4.0

4.3

—

Exclusion endpoint for clefts

108

2.94

6.94

6.6

4.7

—

Acquired absence of organs, not elsewhere classified

3.56

6.93

8.0

3.1

—

Malignant neoplasm of adrenal gland, including Hilmo

4.30

6.92

3.7

5.1

—

Lumbar disc prolapse

866

5287

1.22

6.92

3.4

3.7

—

Disorders of tooth development and eruption

201

1093

1.51

6.88

4.1

3.2

—

Malignant neoplasm of bone and articular cartilage, including Hilmo

120

2.83

6.88

4.4

4.5

—

Haemorrhoids and perianal venous thrombosis

472

3626

1.30

6.88

3.7

3.6

—

Chorioretinal inflammation

197

2.39

6.88

3.7

3.6

—

Otitis externa

314

2292

1.38

6.87

4.9

3.8

—

Acute epiglottitis

3.11

6.85

5.5

3.2

—

Benign neoplasm of middle ear and respiratory system

121

726

1.69

6.84

3.2

4.2

—

!Aliquae complicationes praecoces traumatis

383

1.97

6.84

5.4

3.8

—

Early complications of trauma

383

1.97

6.84

5.4

3.8

—

Dermatophytosis

202

1364

1.50

6.84

5.3

4.0

—

Problems related to social environment

210

2.34

6.83

4.1

3.2

—

Malignant neoplasm of thyroid gland

439

1.89

6.81

5.1

3.8

—

Localized skin eruption due to drugs and medicaments

3.33

6.80

5.8

2.7

—

Open wound of abdomen, lower back and pelvis

236

2.25

6.80

4.6

4.0

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

523

1.81

6.80

4.5

3.3

—

Poisoning by medicine, drug-induced

3.32

6.79

4.6

2.6

—

Acne vulgaris

102

583

1.76

6.78

5.1

3.0

—

Behavioural disorders, excluding more controls

3.06

6.78

6.2

3.8

—

Myelodysplastic syndrome, including Hilmo

230

2.27

6.78

3.5

3.9

—

Unspecified protein-energy malnutrition

4.26

6.76

4.2

3.3

—

Crohn disease (strict definition, require KELA)

484

1.84

6.73

2.8

3.6

—

Intussusception

116

2.82

6.70

3.9

—

Other disorders of bone

248

1748

1.43

6.68

4.4

3.6

—

Other bacterial agents as the cause of diseases classified to other chapters

3.39

6.67

10.5

2.5

—

Cryoglobulinemia

16.77

6.66

5.2

5.0

—

Pruritus

157

1010

1.57

6.66

5.2

3.6

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

522

1.81

6.66

2.8

3.5

—

Thyrotoxicosis with diffuse goitre

164

1065

1.55

6.65

3.0

3.4

—

Other intervertebral disc disorders

1129

5692

1.19

6.62

3.3

3.6

—

Malignant neoplasm of breast, ER-positive, including Hilmo

340

1867

1.36

6.62

3.2

3.3

—

Spontaneous rupture of synovium and tendon

119

717

1.68

6.62

3.3

4.0

—

Drug-induced interstitial lung disorders, unspecified

16.33

6.62

4.3

2.9

—

Cachexia

6.05

6.60

6.2

4.1

—

Any event in hilmo or specialist outpatient

+∞

6.60

3.0

0.0

—

Oesophageal obstruction

306

2.07

6.57

3.2

4.3

—

Alzheimer’s disease (Late onset)

231

2693

0.70

6.57

3.2

3.9

—

Chronic lymphocytic leukaemia

227

2.26

6.56

4.6

4.0

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

227

2.26

6.56

4.6

4.0

—

Chronic lymphocytic leukaemia, helper endpoint

227

2.26

6.56

4.6

4.0

—

Crystal arthropathies, rheuma endpoint

159

2.53

6.53

5.4

3.3

—

Other and unspecified diseases of spleen

6.46

6.50

5.2

3.4

—

Malignant neoplasm of thyroid gland, including Hilmo

497

1.81

6.48

5.0

3.7

—

Crohn disease (strict definition, require KELA, min 2 HDR)

476

1.83

6.46

2.8

3.6

—

Malignant neoplasm of breast, HER-positive

338

1866

1.36

6.43

3.2

3.3

—

Dementia, including avohilmo

746

4164

1.23

6.42

3.2

4.1

—

Somnolence

3.19

6.40

7.4

2.7

—

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

441

1.86

6.39

3.1

2.3

—

Other strabismus

271

1948

1.40

6.38

4.9

3.7

—

Any dementia, excluding more controls

560

3052

1.27

6.38

3.3

3.8

—

Other and unspecified hydrocephalus

143

2.60

6.37

5.4

3.4

—

Diseases of inner ear

765

6035

1.22

6.36

3.5

3.8

—

Other specified/unspecified inflammatory spondylopathies

296

2.06

6.34

2.3

3.5

—

Other noninflammatory disorders of vulva and perineum

117

710

1.66

6.33

3.8

3.3

—

Ulcerative enterocolitis

224

2.24

6.32

3.3

3.6

—

Hypertension, portal

8.41

6.31

5.1

2.1

—

Benign neoplasm of colon, rectum, anus and anal canal

948

6740

1.19

6.29

4.4

3.8

—

Pain in thoracic spine

191

1298

1.48

6.27

3.8

3.7

—

Abscess of external ear

3.15

6.27

5.3

2.3

—

Benign thyroid growths and nodules

409

2923

1.31

6.24

3.7

3.6

—

Car occupant injured in other and unspecified transport accidents

238

1688

1.42

6.22

3.8

3.7

—

Other and unspecified nerve root and plexus disorders, also in other diseases

268

1940

1.39

6.22

3.7

3.8

—

Other and unspecified epidermal thickening

200

2.30

6.22

6.4

4.2

—

Small fibre neuropathy

259

2.14

6.21

4.2

3.8

—

Secondary parkinsonism+Parkinsonism in other disease

226

2.22

6.21

4.5

4.7

—

Injury of urinary and pelvic organs

163

2.46

6.20

4.0

3.3

—

Disorders of vitreous body and globe

726

5648

1.22

6.20

4.6

3.8

—

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

137

864

1.59

6.19

4.9

3.7

—

Selective deficiency of immunoglobulin G [IgG] subclasses

4.31

6.18

5.7

2.9

—

Other appendicitis

113

685

1.67

6.17

4.1

3.9

—

Encephalopathy

3.22

6.15

7.6

3.1

—

Chronic laryngitis and laryngotracheitis

195

1337

1.47

6.15

4.0

3.7

—

Hypertrophic cardiomyopathy

384

1.92

6.15

6.1

4.2

—

Normotensive glaucoma

137

873

1.59

6.14

3.0

4.0

—

Organ-limited amyloidosis

6.41

6.14

2.9

2.7

—

Kela reimbursement Agammaglobulinemia (D80-84)

3.74

6.13

5.1

2.3

—

Juvenile arthritis (FINNGEN)

273

2.08

6.12

4.5

3.5

—

Malignant neoplasm of pancreas, including Hilmo

121

749

1.64

6.09

3.6

3.9

—

Use of antiglaucoma preparations and miotics

124

773

1.63

6.09

4.4

3.9

—

Hypothalamic dysfunction, including iatrogenic, not elsewhere classified

16.85

6.08

11.8

4.5

—

Superficial injury of forearm

137

874

1.58

6.07

4.4

3.7

—

Spondylolisthesis/Spondylolysis

236

1680

1.42

6.06

3.1

3.8

—

Artrosis, including avohilmo

1196

5602

1.17

6.06

3.5

3.8

—

Ventricular septal defect, a heart condition

146

2.52

6.05

4.8

4.5

—

Primary gonarthrosis, bilateral

759

5259

1.21

6.03

3.3

3.9

—

Deficiency of other B group vitamins

147

2.51

6.01

6.4

3.1

—

Inflammatory disease of uterus

147

955

1.55

6.00

3.1

2.9

—

Hypersensitivity angiitis

6.18

5.98

4.7

3.5

—

Diseases of salivary glands

419

3258

1.29

5.97

3.2

3.8

—

Other disorders of optic disc

2.98

5.97

5.7

2.8

—

D07AA Corticosteroids, weak (group I)

192

1318

1.47

5.96

3.5

3.8

—

Mantle cell lymphoma, including Hilmo

107

2.81

5.95

3.1

4.1

—

Toxic liver disease

107

2.80

5.94

4.2

3.1

—

Other psoriatic arthropathies

133

848

1.59

5.93

3.2

4.0

—

Malignant melanoma, including Hilmo

229

1629

1.42

5.93

3.6

3.8

—

Spirochaetal infections, other/unspecified

834

0.45

5.92

5.1

4.0

—

Disorders of vitreous body

702

5504

1.22

5.91

4.6

3.8

—

Fall on same level involving ice and snow

802

6694

1.20

5.91

3.9

3.7

—

Acute appendicitis

933

7320

1.19

5.90

3.9

3.7

—

Fissure and fistula of anal and rectal regions

307

2291

1.35

5.90

3.4

3.5

—

Other diseases of gallbladder

347

1.93

5.87

5.2

3.6

—

Other and unspecified injuries of thorax

131

2.59

5.86

3.1

3.5

—

Acute nasopharyngitis (common cold)

147

953

1.54

5.85

3.2

3.5

—

Allergic urticaria

105

634

1.68

5.84

3.8

3.5

—

Congenital malformations of gallbladder, bile ducts and liver

3.47

5.81

14.8

2.5

—

Personal history of medical treatment

3.57

5.80

5.5

2.6

—

Congenital malformations and deformations of the musculoskeletal system

109

662

1.65

5.79

5.1

3.6

—

Other specified/unspecified necrotizing vasculopathies

103

2.82

5.79

6.4

3.0

—

Other extrapyramidal and movement disorders in other diseases

339

2576

1.33

5.77

3.5

3.8

—

Other congenital malformations of heart

6.36

5.77

2.0

5.0

—

Psoriasis vulgaris

247

1789

1.39

5.77

4.5

3.9

—

Injury of intra-abdominal organs

188

2.29

5.74

5.7

3.5

—

Alcoholic gastritis

115

2.70

5.73

5.0

4.7

—

Psoriatic arthropathies, ICD10

135

871

1.57

5.73

3.2

4.0

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

213

2.19

5.73

5.7

3.8

—

Other maternal disorders predominantly related to pregnancy

567

2851

1.25

5.72

3.2

3.3

—

Nonspecific lymphadenitis

400

1.85

5.71

4.8

3.6

—

Postprocedural disorders of nervous system

458

1.79

5.70

3.9

2.9

—

UC patients in KELA-register (code 208), prior to 1994

344

1.93

5.70

3.8

4.0

—

Malignant neoplasm of rectosigmoid junction, including Hilmo

208

2.21

5.69

4.1

4.2

—

Stomatitis and related lesions

261

1913

1.37

5.66

3.8

—

Cluster headache, wide,, including avohilmo

387

1.86

5.66

4.0

3.2

—

Need for other prophylactic measures

460

1.79

5.65

4.4

4.2

—

Malignant neoplasm of corpus uteri

103

625

1.67

5.64

3.3

3.5

—

Vulvovaginal ulceration/inflammation in other diseases

431

1.81

5.61

4.1

2.9

—

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

2.85

5.61

1.7

2.1

—

Acetic acid derivatives and related substances

444

1790

1.29

5.61

4.1

4.5

—

Inflammatory diseases of prostate (prostatitis)

196

1372

1.44

5.60

4.5

4.3

—

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

105

2.77

5.60

5.0

4.0

—

Follicular lymphoma, hilmo

368

1.89

5.58

3.3

4.0

—

Use of rotigotine

3.17

5.58

4.6

3.2

—

Pregnancy hypertension

409

2853

1.29

5.58

3.7

3.1

—

Fall on and from stairs and steps

356

2738

1.31

5.57

4.2

3.8

—

General examination and investigation of persons without complaint and reported diagnosis

957

4204

1.19

5.56

3.8

3.6

—

Anisometropia and aniseikonia

250

2.08

5.56

5.2

3.7

—

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

6.14

5.55

5.9

5.4

—

Other and unspecified trigeminal disorders

111

2.69

5.55

1.8

3.5

—

Gonarthrosis,primary

1298

6797

1.15

5.53

3.5

3.9

—

Haemolytic-uraemic syndrome

8.77

5.53

9.7

3.7

—

Malignant immunoproliferative diseases

3.08

5.52

5.5

3.3

—

Malignant neoplasm of head and neck

109

675

1.63

5.51

4.1

—

Autoimmune hyperthyroidism

383

1.85

5.51

3.8

3.3

—

Carpal tunnel syndrome

816

5945

1.19

5.50

3.5

3.7

—

Other disorders of amino-acid metabolism

5.98

5.50

5.0

5.6

—

SLE (Finngen)

185

2.25

5.48

4.6

3.6

—

Peritonsillar abscess

255

1873

1.37

5.47

3.6

—

Other enthesopathies

361

2787

1.30

5.46

3.6

3.7

—

Myeloproliferative diseases (CML excluded)

114

717

1.61

5.45

3.6

4.0

—

Burn and corrosion of trunk

232

2.11

5.44

3.1

3.7

—

Universal erythroderma, KELA reimbursement

101

2.76

5.42

4.7

3.3

—

Other crystal arthropathies

174

2.31

5.41

5.4

3.3

—

Secondary parkinsonism

226

2.13

5.41

4.6

4.4

—

Antenatal screening

113

996

0.63

5.39

2.0

3.1

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

107

2.69

5.38

3.8

4.8

—

Other specified/unspecified spondylopathies

187

2.24

5.38

5.1

4.0

—

Lupus nephritis

7.15

5.37

8.4

2.1

—

Exposure to other specified factors

1121

8316

1.16

5.37

3.9

3.7

—

633

4693

1.22

5.37

4.4

3.8

—

Haemorrhage in early pregnancy

266

1915

1.36

5.35

2.7

3.1

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

455

3136

1.26

5.34

3.8

3.1

—

Abnormal findings in nipple discharge synovial fluid wound secretions

2.79

5.34

5.2

2.3

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

354

2736

1.30

5.34

2.8

3.7

—

Aspergillosis

3.18

5.32

4.3

2.9

—

Abnormal reflex

4.89

5.31

5.4

2.9

—

Malignant neoplasm of pancreas

605

1.66

5.31

3.7

4.1

—

Superficial injury of shoulder and upper arm

161

1097

1.48

5.31

3.3

3.9

—

Small cell lung cancer

201

2.18

5.31

3.8

4.1

—

Small cell lung cancer, including Hilmo

201

2.18

5.31

3.8

4.1

—

Other and unspecified urticaria

237

1730

1.38

5.30

4.0

3.7

—

Other specified/unspecified systemic involvement of connective tissue

403

1.81

5.29

5.0

3.9

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

191

1344

1.43

5.29

3.4

3.0

—

Malignant neoplasm of larynx

114

2.62

5.28

4.8

4.0

—

Intracerebral haemorrhage

194

1371

1.43

5.28

4.1

4.0

—

Gonarthrosis, primary, with knee surgery

851

5607

1.19

5.28

3.4

3.9

—

Disorder of pancreatic internal secretion, other and/or unspecified

3.63

5.26

5.9

2.7

—

Suggestive for eosinophilic asthma

121

778

1.57

5.26

4.4

3.8

—

Infections with a predominantly sexual mode of transmission

332

2544

1.31

5.24

5.0

3.3

—

Fracture of neck

608

1.65

5.24

4.5

4.2

—

Phakomatoses, not elsewhere classified

3.32

5.23

5.0

4.4

—

Retinal detachment with retinal break

182

1275

1.44

5.21

4.4

4.1

—

Aspergillosis, including avohilmo

3.13

5.20

4.3

2.9

—

Proteinuria and renal glomerular damage; focal glomerulonephritis

9.62

5.19

12.2

3.9

—

Nutritional marasmus

11.17

5.18

2.7

4.0

—

Triptan medication for migraine, min. 3 purchases

626

3854

1.22

5.18

2.8

3.5

—

Speech and linguistic disorders

113

687

1.59

5.16

4.0

3.9

—

Intermittent heterotropia

420

1.78

5.16

6.3

3.7

—

Malignant neoplasm of other connective and soft tissue

171

2.27

5.16

2.6

3.8

—

Carcinoid syndrome

3.21

5.15

3.3

—

Alkalosis

10.90

5.15

10.3

2.9

—

Malignant melanoma

198

1411

1.41

5.14

3.6

3.9

—

Agoraphobia

184

2.21

5.12

2.8

2.7

—

Adenocarcinoma and ductal carcinoma of pancreas

272

1.98

5.11

2.8

3.9

—

Mixed connective tissue disease

110

2.61

5.10

3.7

3.3

—

Brain glioblastoma and astrocytoma

110

2.61

5.10

1.9

3.6

—

Hyperprolactinaemia

191

2.18

5.10

5.4

2.4

—

Malignant neoplasm of vulva

3.39

5.09

2.8

3.1

—

Shock, not elsewhere classified

3.38

5.09

7.6

3.3

—

Persons encountering health services in circumstances related to reproduction

494

4088

0.81

5.09

3.4

3.9

—

Campylobacter enteritis

185

2.21

5.08

4.3

3.3

—

Carcinoma in situ of other and unspecified sites

432

1.77

5.08

3.6

4.2

—

Ulcer of vagina/vulva

185

2.20

5.08

4.4

3.1

—

Personal history of allergy to drugs, medicaments and biological substances

3.49

5.07

4.9

2.2

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

176

1232

1.44

5.06

3.5

3.8

—

Retinal detachments and breaks

496

4021

1.24

5.05

4.3

3.8

—

Demyelinating diseases of the central nervous system

582

1.65

5.05

3.0

3.2

—

Other disorders of central nervous system

3.05

5.04

3.3

4.4

—

Other congenital malformations of kidney

5.82

5.04

7.8

5.0

—

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

160

2.30

5.03

3.2

3.6

—

Other and unspecified acquired haemolytic anaemias

3.15

5.03

4.5

3.0

—

Congenital malformations of the nervous system

135

2.42

5.02

3.7

3.6

—

Systemic sclerosis (FG)

135

2.42

5.02

5.5

3.0

—

Varicella [chickenpox]

359

1.84

5.02

5.4

3.7

—

Corneal ulcer

236

1739

1.37

5.01

4.8

3.9

—

Carbimazole or st.post thyroidectomy, condition for graves disease

246

1825

1.36

5.00

3.4

3.6

—

Arthropod-borne viral fevers and viral haemorrhagic fevers

127

836

1.54

5.00

3.5

4.1

—

Acute myeloid leukaemia

2.94

4.98

4.4

3.3

—

Acute myeloid leukaemia, including Hilmo

2.94

4.98

4.4

3.3

—

Acute myeloid leukaemia, helper endpoint

2.94

4.98

4.4

3.3

—

Restless leg syndrome

188

1337

1.42

4.96

3.2

3.9

—

Pain associated with micturition

155

1064

1.47

4.96

4.0

3.9

—

Calcinosis cutis

10.03

4.93

10.2

1.5

—

Other/unspecified synovitis and tenosynovitis

143

967

1.49

4.93

3.9

3.6

—

Polycystic ovarian syndrome

325

1.87

4.91

2.4

2.1

—

Cervicalgia

262

1968

1.34

4.91

2.9

3.7

—

Polymyalgia rheumatica

198

1425

1.40

4.90

3.6

4.0

—

Other adrenocortical overactivity

5.07

4.90

8.0

3.8

—

Other secondary gonarthrosis

466

1.72

4.89

4.0

3.9

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

298

1.91

4.88

4.4

4.0

—

Skin changes due to chronic exposure to nonionizing radiation

601

4511

1.21

4.86

4.3

3.8

—

Other peripheral vertigo

128

850

1.52

4.85

2.9

4.0

—

Hypoplasia of dental enamel, prenatal

8.14

4.85

20.9

7.7

—

Actinic keratosis

589

4435

1.21

4.85

4.3

3.8

—

Other/unspecified crystal arthropathies

3.58

4.84

4.1

4.7

—

Other and unspecified primary disorders of muscles

3.72

4.83

6.5

2.6

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

3.41

4.83

5.1

3.2

—

Monoarthritis, not elsewhere classified

306

1.89

4.83

4.3

3.4

—

Viral meningitis, including avohilmo

257

1.98

4.82

3.4

3.3

—

Mumps

183

2.18

4.81

3.3

3.1

—

Cystic fibrosis

7.87

4.79

6.3

2.0

—

Other drug-induced secondary parkinsonism

3.05

4.79

7.2

2.7

—

Retinal vascular disorders

179

1272

1.42

4.78

4.4

4.0

—

Malignant neoplasm, without specification of site

251

1.99

4.78

3.2

4.0

—

Malignant neoplasm of vulva, including Hilmo

2.86

4.77

3.4

3.1

—

Ocular pain

109

701

1.57

4.77

3.9

3.6

—

Cluster headache, strict, including avohilmo

365

1.81

4.77

4.2

3.2

—

Other diseases of peritoneum

329

1.85

4.77

3.8

3.7

—

Disorder of the sleep-wake schedule

114

2.51

4.76

3.7

3.5

—

Other juvenile arthritis

251

1.98

4.76

4.7

3.5

—

Dementia

679

3888

1.20

4.75

3.1

4.0

—

Neuroendocrine tumor and carcinoma of small intestine

2.78

4.74

3.9

3.1

—

Burns and corrosions

178

1266

1.42

4.72

3.9

4.0

—

Henoch-Schönlein purpura nephritis (HSPN)

5.85

4.72

8.7

2.4

—

Otalgia

109

703

1.57

4.71

4.0

3.9

—

Amblyopia ex anopsia

316

1.86

4.71

6.3

4.2

—

Retinal vascular occlusion

176

1251

1.42

4.70

4.3

4.0

—

Benign neoplasm of thyroid gland

225

2.04

4.70

3.8

3.3

—

Acne, including avohilmo

240

1443

1.35

4.70

5.1

3.1

—

Infectious mononucleosis, including avohilmo

586

1.62

4.69

4.1

2.8

—

Infectious mononucleosis

586

1.62

4.69

4.1

2.8

—

Malignant neoplasm of larynx, including Hilmo

159

2.26

4.69

5.2

4.1

—

Congenital malformations of trachea and bronchus

3.01

4.68

8.6

3.8

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Gas panel - Central venous blood

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS